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1General introduction 
Until 2010, palliative care was mainly restricted to terminal, reactive care, and to patients 
with cancer. The GP, being the most appropriate professional to coordinate palliative care 
for home-dwelling patients, needed tools to be able to identify his palliative patients early in 
time, and asked for training in proactive palliative care planning. My thesis contains several 
studies, aiming to meet these needs.
Mr Roos 80 years old, known for years with congestive heart failure (CHF), visits the depart-
ment of cardiology every 2 weeks to get rid of the overload of fluid. Ten years ago he got an 
implantable cardioverter defibrillator (ICD). He has big faith in the cardiologist and the nurses 
of the department. Together with his wife he lives in a semidetached house with a big garden. 
In the past year, he visited his general practitioner (GP) twice: once because he suffers from little 
pains in his hands and once because of some spots on his skin. (This case illustrates throughout 
the introduction different aspects of a palliative care trajectory for patient and his family.)
the definition of palliative Care
In this thesis the definition of the World Health Organisation (WHO) is used. In 2002, the 
WHO launched an adapted definition of palliative care: an approach that improves the quality 
of life of patients and their families facing the problems associated with life-threatening 
illness, through the prevention and relief of suffering by means of early identification and 
impeccable assessment and treatment of pain and other problems, physical, psychosocial 
and spiritual.1 The WHO is not explicit what ‘early identification’ means, and gives no guide-
lines for how such multidimensional, anticipatory care can be provided. This thesis tries to 
find answers for these challenges.
palliative Care in a historiCal Context
During the crusades (1096-1272), sick pilgrims and citizens received care in hospices (xeno-
dochia) and houses. These hospices and houses disappeared later on as a result of the 
development of modern medicine and the fact that hospitals came into being.2 
‘Modern’ palliative care started with the body of thoughts and work of Cicely Saunders, 
as a reaction on the curative focus of medicine. In the sixties of the previous century, she 
founded the first ‘modern’ hospice in England, a place where holistic care of the terminal 
patient was provided, where also the family felt welcome, and where the patient could die 
peacefully.3 In the next decades, several other hospices were founded, not only in Great 
Britain, but also in the United States and Australia. It took some more time before hospices 
were built in other European countries. 
For the first time in 1973, the term ‘palliatieve zorg’ was used in Dutch medical literature, 
as a translation of ‘palliative care’, this was introduced in the same year by the Canadian 
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physician Balfour Mount.4,5 Mount was inspired by Cicely Saunders and Elisabeth Keble 
Ross. In 1969, Elisabeth Keble Ross, an American psychiatrist, published a book titled ‘On 
death and dying’. In this book, with the subtitle ‘what the dying have to teach doctors, nurses, 
clergy, and their own families’, for the first time structural attention was given to the emo-
tions of terminal patients and their families.6 
palliative Care in the netherlands
Until 1988, care for the dying was provided by GPs, nursing home physicians, or by the 
medical specialist. In the Netherlands palliative care is not a different specialty; every 
physician, also including the GP, is expected to provide this care.7 Following other countries, 
in 1988 the first hospice, ‘bijna-thuis-huis Nieuwkoop’ was founded.5 At that time, coopera-
tion and information transfer between primary and secondary care was not organised in a 
structured way, and 24/7 accessibility of general practitioners was not guaranteed. These 
gaps in continuity of care, in combination with a lack of knowledge and skills regarding 
end-of-life care of GPs contributed to a growing criticism on as well the content as the 
organisation of palliative care. With this growing dissatisfaction the first specialistic pallia-
tive care teams were established in hospitals, as well as consultation teams in primary care.8 
The latter provide 24/7 telephone advice and support about palliative care aspects to pro-
fessional caregivers. As these consultation teams were initiated by and belonged to the 
comprehensive cancer centres (IKNL), they historically were cancer-oriented and mainly 
demand-driven. They advice GPs who seek help when they were confronted with problems 
in the terminal stage of life of their patients with cancer.9
The role of GPs in palliative care provision
Palliative care is an essential aspect of the care provided by GPs. GPs are generalists, have 
an important role in the continuity of care, are context-oriented and demand-driven.10 
Almost each inhabitant of the Netherlands is registered on the patient list of a specific GP; 
this GP is responsible of the generalistic care of the patient. By having this role, the GP 
theoretically knows what health issues the patient has as well as the patient’s context. By 
this central position in the health care system and the above mentioned characteristics, 
the GP is the professional who coordinates and provides palliative care for home-dwelling 
patients.11-14 
As diagnosis of incurability of a life-limiting disease usually takes place in the hospital, the 
medical specialist might be the appropriate physician to define a patient as palliative. How-
ever, also medical specialists experience barriers to adapt the focus from curative to a pallia-
tive intent.12,15 For this reason, in combination with suboptimal information transfer, GPs 
lose touch with these patients. To facilitate GPs in catching sight of these patients again 
and in taking responsibility again, tools might be helpful.
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Epidemiology in general practice
Around the period I started my PhD-trajectory, the standard practice size was about 2350 
patients per full time equivalent GP.16 In 2006, yearly mortality in the Netherlands was 
about 135,000 of which 77,000 people (57%) died of a malignant or (other) chronic disease. 
This means, that in a norm general practice per year a mean of 11 patients dies non-acutely 
and in theory could be considered to be palliative patients in their final phase of life.17,18 This 
number is expected to further increase in the next decades as a result of the aging popula-
tion and longer life expectancy.19 
In the Netherlands, 75% of the population prefers to die at home, but 31% actually does,20 
which is relatively high in comparison to other countries.21 
Do not harm 
The Hippocratic Oath is an oath historically taken by physicians. Although it is inaccurate 
that ‘Primum non nocere’ (First do no harm) is part of it, it does state that a physician will 
take care of the sick, will do no harm, will promote health, and will relieve suffering.22,23 Of 
course, this also concerns GPs. ‘Primum non nocere’ is an important starting point of general 
practice,10 which also can be explained as protecting against unnecessary treatments. 
Examples of this are waiting for the natural cause of a self-limiting disease or discontinua-
tion of or deciding not to start investigations or treatment with a curative intent in case of 
an inevitable lethal disease. A prerequisite to meet this core value is consensus between 
GP, patient and his family regarding the disease and its consequences. To reach this, the GP 
needs to timely recognise and realise that solely curative treatment will have no positive 
effects anymore. At that moment, ‘relief of suffering’, as part of the Hippocratic oath, is the 
primary goal of care: palliative care. 
Challenges GPs meet in providing palliative care
GPs consider palliative care a fascinating and important aspect of their profession, but 
also consider early identification of those patients that might profit of palliative care as 
well as their own coordinating role a challenge.14,24,25 In 2009, the Dutch College of General 
Practitioners (NHG) published their point of view on palliative care, called ‘Huisarts en pal-
liatieve zorg, fijn dat u er bent dokter’ (‘General practitioner and palliative care, nice that 
you are here doctor’), aiming to contribute to the quality and further professionalisation of 
the care for the dying and their family.26 In this point of view, several recommendations 
regarding palliative care planning, continuity of care and GP training are provided.
The most recent Dutch GP competences profile of 2009 contains some attention for pallia-
tive and terminal care.27 Every GP is supposed to have some knowledge and experience in 
palliative care, and knows the bio psychosocial model. Knowledge and experience varies 
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between GPs, as it is also related to experience with and interest in palliative care. Factors 
that contribute to experience are the length of time of practicing as a GP, and the age division 
of patients in the practice. GPs stated to be unsure about their competences in palliative 
care.24 If they come across specific problems when providing palliative care, they can ask for 
advice by phone from a consultation team, or from a GP who has had a specialised training 
in palliative care. About 1% of all practicing GPs in the Netherlands has completed such a 
specialised training.28 
With respect to the continuity of GP care, a lot has changed in the past decades. Until the 70s, 
a GP almost always worked in a single-handed practice; in that period only 2% worked in a 
group practice. Thirty years later, in 2005, 42% of the GPs worked in a group practice.29 
As a solution for the high 24/7 availability burden, another large organisational change in 
general practice started: out-of-hours GP cooperative.30 This development challenged 24/7 
continuity of palliative care within practices. 
Reactive versus anticipatory care
GPs mainly work demand-driven: a patient asks for a consultation because he has a symp-
tom, problem or question, and the GP has the knowledge and skills to provide an answer. 
However, already in 1970 van den Dool introduced anticipatory health care: by monitoring 
of a population at risk, some chronic diseases can be detected in an early stage. This type of 
anticipatory care was introduced as part of the daily practice of GPs,31,32 but forty years 
later anticipatory care in patients who suffer from an advanced or end-stage chronic, life-
limiting disease still hardly takes place. In order to be able to provide anticipatory palliative 
care the GP needs identification of those patients in need of it, to have insight in the possible 
future scenarios, and knowledge how to discuss these with the patient. 
In summary, the challenges that GPs face in providing palliative care are mainly experienced 
in early identification of palliative care patients and an anticipatory approach of care.
At home Mr Roos still enjoys his garden although he cannot maintain it as he would like. The 
grass is growing everywhere. His son builds him a little green house where he can stand up 
straight. Years ago, before his heart attack, he arranged it all by himself. But as years went by 
he suffers more and more from his dyspnoea. Sometimes he is scared to choke and to leave his 
wife and children behind without saying goodbye.
identifiCation of the palliative patients
The WHO definition of palliative care states that early identification of the patient in need for 
it can improve the quality of palliative care.1 Such early identification might not only con-
tribute to relieving existing problems, but also to anticipating on possible future problems, 
needs and wishes of the patient. Yet, despite the worldwide acceptance of this aspect of the 
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WHO definition, early identification was a first challenge, as no scientifically sound tools or 
guidelines existed to facilitate it.33 Although quite some studies about prognostication of 
mortality, survival or prognosis of patients with cancer or a chronic, life-limiting disease 
had been published, they don’t provide an answer to the question which patients are in 
need of palliative care:34-41 The latter is more related to having lost resilience, or having an 
increased risk to deteriorate or die.
Palliative care models
In line with the WHO definition, Lynn and Adamson developed a new palliative care model, 
as an alternative for the, at that moment current model in which a clear boundary in time 
existed between curative and palliative care.42 In the new model palliative care needs already 
exists simultaneously with curative care. (Figure 1)
However, this alternative model is a simplification; it does not take account of the different 
disease trajectories.43 (Figure 2) 
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figure 1 - the older “transition” Model of care Versus a “trajectory” Model.42
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figure 2 - trajectories of late-life illness62
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Three main trajectories can be distinguished:
1. Patients with cancer often start with a longer quite stable period, and after this a rela-
tively fast decline until death. 
2. Patients with chronic organ failure, like chronic obstructive pulmonary disease (COPD) 
or CHF have a long period of slow functional decline, with acute exacerbations of their 
disease and a sudden death, often during an exacerbation. 
3. (Older) patients with frailty or dementia have a long period of slow functional decline 
until death. 
Such a general description of disease trajectories can be helpful for physicians in deciding 
when to start palliative care, but also has its limitations. The time between diagnosis of a 
life-threatening disease and death can vary between weeks and decades. In the period fol-
lowing diagnosis, there is not always a need for extra care. Besides, often patients deny 
having a life-limiting disease, and are learning how to live with it. Starting palliative care 
or talking about the end of life in this stage often seems unrealistic, and in some cases even 
undesirable. It even might cause medicalisation and might be superfluous. 
On the other hand, difficulties in predicting mortality, prognosis, and survival might also 
cause a prognostic paralysis of the physician, caused by concerns to take away hope or to 
burden the patient and relatives.44
The right moment? 
Taking these deliberations into account: what might be the correct moment to start pallia-
tive care? (Figure 3) 
As an attempt to answer this question, the developers of the Gold Standards Framework 
(GSF) published for several chronic diseases a number of aspects on their website, that could 
be used as a trigger to start talking with a patient and family about end-of-life decisions 
and wishes.45 In 2008 the ‘surprise question’ was introduced; a question a physician asks 
himself: ‘Would I be surprised if this patient were to die in the next 12 months?’46 In the 
period that I started my PhD-trajectory, neither the GSF nor the surprise question were 
validated; no single scientific publication about the GSF was available. 
Early identification of patients that might benefit from palliative care enables to merge pal-
liative care with disease-oriented treatment. It has been shown that palliative care improves 
satisfaction with care, and decreases acute interventions, like hospitalisations.47-50 Besides, 
it increases the percentage of patients that die at home, which is the preferred place to die 
of the majority of the Dutch population.51 
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proaCtive palliative Care planning
A next challenge concerns the second part of the WHO definition1: the prevention and relief 
of suffering by means of early identification and impeccable assessment and treatment of 
pain and other problems, physical, psychosocial and spiritual. To reach this aim, a thorough 
assessment of actual symptoms and needs as well as possible future scenarios is needed, in 
which as well the person, his disease and his social context are considered. Palliative care 
programmes appear to decrease distress and to increase patient and family caregiver satis-
faction. Important elements of proactive palliative care planning are: discussing expected 
disease scenarios and advantages or disadvantages of several options for interventions, 
expected dying scenarios, advance care planning like treatment restrictions,52-54 family 
strength and burden, and an assessment of physical, psychological, social and existential 
problems and needs.55,56 Structured palliative care showed to increase the chance to die at 
home,57,58 to decrease unexpected transfers,59 length of hospitalisation and aggressive 
interventions, which appears to be cost-effective.47,59 All these aspects contribute to the 
quality of the limited remaining life of patients and their families. 
In our opinion, proactive palliative care planning is not limited to a single conversation 
with the patient, but asks for a series of conversations in the course of the palliative care 
trajectory. The above-mentioned aspects of proactive palliative care are discussed during 
these meetings with the patient and his family caregiver, in which plans, wishes and needs 
can be adapted to new insights over time as often as needed. 
As for patients with chronic diseases and cancer often the medical specialist remains 
responsible for the disease-oriented treatment until an advanced stage of their disease, it 
figure 3 - What is the moment to start palliative care? a modified figure of lynn and Adamson42
time
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is a challenge for GPs to early identify the need for palliative care and to provide structured 
care planning for these patients simultaneously.13
As mentioned before, GPs work mainly demand-driven and provide reactive care. Proactive 
palliative care planning needs other habits and appeals to other skills. It does not follow a 
clear protocol, and asks professional creativity or out of the box thinking and acting. By 
recognising patterns of disease scenarios, the GP will be facilitated to set out a proactive 
policy or treatment plan, anticipating on possible complications.60,61 
Mr Roos is still very fond of Ms Roos. Last year they celebrated their 60 years of marriage. 
They both loved it. Ms Roos is very concerned about the health of her husband. Almost every 
night she is afraid to go to bed. What if... he is so afraid, he is choking, he stops breathing, and 
he is going to die. She herself has difficulties walking because of osteoarthritis. Lately, she feels 
a little depressed. And she feels guilty that the care for her husband feels like a burden. 
outline of this thesis
The aim of this thesis was to study training general practitioners in early identification 
and proactive palliative care planning of patients in need of palliative care from different 
perspectives.
The following sub-questions will be studied.
1. Can we systematically develop a tool for GPs for early identifying patients with CHF, COPD, 
and cancer respectively, who could benefit from proactive palliative care planning?
2. Does training of GPs in early identification and proactive palliative care planning improve 
the outcome of palliative patient with CHF, COPD and cancer as compared to untrained 
GPs?
3. What are the long-term effects of training GPs in early identification and proactive pal-
liative care planning in the number of identified palliative patients and the content of 
the provided palliative care, as compared to untrained GPs, and what is the effect of the 
identification tool?
4. How do palliative care specialist consultants and trained GP’s evaluate the training in 
early identification and proactive palliative care planning?
In chapter 2 we report the development of the RADboud indicators for PAlliative Care needs 
to identify those patients with cancer, COPD or CHF that might profit of a palliative care 
approach. In chapter 3 we report the incentive for and methods of the randomised controlled 
trial (RCT) to study the effect of a training in early identification of and proactive palliative 
care for GPs. Chapter 4 reports the results of the RCT: Training general practitioners in 
early identification and proactive palliative care planning. Chapter 5 describes the effect of 
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training general practitioners in early identification of their palliative patients and chapter 6 
describes how GPs and specialist consultants evaluated several aspects of the training and 
its impact on their daily practice. 
Finally, in the general discussion and conclusions we summarise our findings and place these 
in perspective of the contemporary situation and give some direction of future research 
(Chapter 7).
After a period in which he weekly went to hospital day care for management of fluid overload, 
in a shared decision making process of Mr Roos and his wife, the GP, the cardiologist, it was 
decided to inactivate the implantable cardioverter defibrillator (ICD), and to extend home 
care. The next day’s Mr Roos became tired, dead tired, and very short of breath. Medications 
don’t provide relief anymore. He bides farewell to his wife, his children and his life. In the end he 
was sedated to relief his intractable symptoms and died at home amidst his wife and children. 
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Background
According to the World Health Organisation (WHO) definition, palliative care should be 
initiated in an early phase and not be restricted to terminal care. In the literature, no validated 
tools predicting the optimal timing for initiating palliative care have been determined.
Aim
The aim of this study was to systematically develop a tool for GPs with which they can iden-
tify patients with congestive heart failure (CHF), chronic obstructive pulmonary disease 
(COPD), and cancer respectively, who could benefit from proactive palliative care.
Design
A three-step procedure, including a literature review, focus group interviews with input 
from the multidisciplinary field of palliative healthcare professionals, and a modified Rand 
Delphi process with GPs.
Method
The three-step procedure was used to develop sets of indicators for the early identification 
of CHF, COPD, and cancer patients who could benefit from palliative care.
Results
Three comprehensive sets of indicators were developed to support GPs in identifying 
patients with CHF, COPD, and cancer in need of palliative care. For CHF, seven indicators 
were found: for example, frequent hospital admissions. For COPD, six indicators were found: 
such as, Karnofsky score ≤50%. For cancer, eight indicators were found: for example, worse 
prognosis of the primary tumour.
Conclusion
The RADboud indicators for PAlliative Care needs (RADPAC) is the first tool developed from 
a combination of scientific evidence and practice experience that can help GPs in the identifi-
cation of patients with CHF, COPD, or cancer, in need of palliative care. Applying the RADPAC 
facilitates the start of proactive palliative care and aims to improve the quality of palliative 
care in general practice.
Abstract
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introduCtion
In the UK and in the Netherlands, the large majority of deaths are due to circulatory disease, 
respiratory disease, or cancer.1,2 In a substantial number of these cases, death resulted after 
a protracted end stage that may often last over a year: the palliative stage. Most patients 
prefer to spend the final phase of their lives primarily at home and also prefer to die there,1,3 
making the GP the most appropriate healthcare professional to initiate, provide and coor-
dinate palliative care.4-7 Yet, only a minority of these palliative patients die at home.3,8,9 
According to the World Health Organisation (WHO) definition, palliative care should be 
initiated in an early phase and not be restricted to terminal care.10 However, to date, pallia-
tive care is often restricted to physical symptom relief in the terminal phase, including emer-
gency visits by the GP,11 transfers,12 and unplanned hospital admissions.13,14 Consequently, 
too many patients die in another place than preferred.15,16 By recognising the needs of pallia-
tive cancer and non-cancer patients earlier, proactive care planning (including assessment 
and treatment of the physical, psychological, spiritual, and social consequences of the 
patient’s situation and condition) might improve the quality of their remaining life. Never-
theless, early identification of patients who can benefit from palliative care is challenging. 
In patients with chronic obstructive disease (COPD) or congestive heart failure (CHF), but 
also in patients with advanced cancer, disease trajectories can last many years. Therefore, 
it is difficult to mark on the gradual slope of the different disease trajectories the moment 
when palliative care could be beneficial alongside or instead of disease-oriented therapies 
(Figure 1).6,17-20 In published studies, unidentified palliative care patients with (non-cancer) 
chronic diseases received fewer drugs for palliation than patients with cancer, while the 
symptom burden was at least comparable.21,22 Furthermore, end-of-life issues and preferred 
place of death are more frequently discussed with cancer patients than with patients with 
life-threatening non-cancer diseases.22,23 Particularly with regard to non-cancer chronic 
time
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Follow-up care 
informal  
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general practitioner 
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figure 1 - What is the moment to start palliative care? a modified figure of lynn and Adamson59
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diseases, clinicians do not know when to initiate or how to communicate a palliative care 
approach.6,24-26 For GPs in the UK, there are financial incentives for participating in the system 
for performance management and payment, including the timely inclusion of patients in 
the palliative care register.27 Palliative care providers, including GPs, report that the most 
important gap is the lack of prognostic indicators and clinical triggers for initiating pallia-
tive care.28 As physicians tend to overestimate the survival of their patients,29,30 the use of 
the single surprise question: ‘Would I be surprised if the person in front of me died in the 
next six months or one year?’ as a prompt to initiate discussions about end-of-life needs 
and preferences is regarded as inappropriate. Small et al. suggest making it more explicit 
for patients with CHF and COPD.31 In 2008, in the UK’s Department of Health published an 
end-of-life care strategy, in which identifying people approaching end of life is one of the 
key subjects.32 This strategy is partly based on the Gold Standards Framework (GSF). GPs in 
the UK are familiar with this GSF, which includes a prognostic indicator guide.33 Yet the 
indicators used in the GSF are not evidence-based. To date, the study has been unable to 
identify any validated tools predicting the optimal timing for initiating palliative care,34 
although a great deal of research has focused on predicting mortality, survival, and prog-
nostication.35-43 Therefore, the aim of this study is to systematically develop a tool to identify 
patients with CHF, COPD and cancer respectively, based on the combination of evidence 
and practice-based knowledge. This tool could be used in regular patient contacts to help 
identify patients in need of palliative care and thus serve as a starting point for (proactive) 
palliative care.
Methods
Design
A three-step procedure was used to develop sets of indicators for the early identification 
of patients with CHF, COPD and cancer who could benefit from palliative care.
Firstly, a structured Pub Med literature review was performed (Box 1; Figure 2, step 1). The 
cross references and the Oxford Textbook of Palliative Medicine, and relevant national and 
international websites were checked. Inclusion criteria used were English language, human 
research and patients aged >18 years. The titles and abstracts of the articles found in relation 
to potential indicators for identifying palliative patients were examined. A potential indicator 
was defined as ‘a characteristic, factor, or aspect suggested as a possible indicator predicting 
or influencing prognosis, survival, or transition from a curative to a palliative trajectory in 
CHF, COPD and cancer’. If an abstract mentioned potential indicators, the full text was read. 
Information was collected on study design, population, research question, outcome and 
extracted potential indicators (Additional file 1). 
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Secondly, as it was expected that the indicators found in the literature search would mainly 
concern prognostication or survival and not early identification of palliative patients, three 
focus group interviews were organised. These focus groups respectively discussed CHF, 
COPD and cancer (Figure 2, step 2) with GPs and experts in the respective fields, all with a 
focus on palliative care. The focus group interview was led by an experienced moderator, to 
discuss the applicability of each indicator for early identification and to suggest additional 
indicators based on clinical experience. The panel prepared themselves by performing a 
web-based survey enabling them to consider their own strategy for identifying patients 
who might benefit from palliative care. During the focus group interview, an inventory was 
made of their indicators and these were compared to those found in literature. When con-
cordance existed between an indicator found in literature and that suggested by the group, 
this indicator was accepted. If this concordance did not exist, a discussion followed to reject 
or accept it as a possible indicator. A possible indicator was rejected or accepted if a majority 
of the experts did or did not agree, respectively, on its usefulness. All experts had at least 
five years’ experience in the respective fields of CHF, COPD or oncology.  
Box 1 - search strategy 
“Heart Failure”[Mesh] And (“Palliative care”[Mesh] or “Mortality”[Mesh] or 
“Prognosis”[Mesh] or “survival”[Mesh] or “Health status indicators”[Mesh] or 
Prognostication[tw] or end of life care[tw] or “Advance care Planning”[Mesh]) And 
(“humans”[Mesh terms] And english[lang] And “adult”[Mesh terms] And (“1”[PdAt] : 
“2008/07/01”[PdAt]))
“Pulmonary disease, chronic obstructive”[Mesh] And (“Palliative care”[Mesh] or 
“Mortality”[Mesh] or “Prognosis”[Mesh] or “survival”[Mesh] or “Health status 
indicators”[Mesh] or Prognostication[tw] or end of life care[tw] or “Advance care 
Planning”[Mesh]) And (“humans”[Mesh terms] And english[lang] And “adult”[Mesh 
terms] And (“1”[PdAt] : “2008/07/01”[PdAt]))
“neoplasms”[Mesh:noexp] And (“Palliative care”[Mesh] or “Mortality”[Mesh] or 
“Prognosis”[Mesh] or “survival”[Mesh] or “Health status indicators”[Mesh] or 
Prognostication[tw] or end of life care[tw] or “Advance care Planning”[Mesh]) And 
(“humans”[Mesh terms] And english[lang] And “adult”[Mesh terms] And (“1”[PdAt] : 
“2008/07/01”[PdAt]))
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step1 - literature search
Aim: exploration in literature of potential indicators
step2 - focus group interviews
Aim: transition to identification of palliative patients
step3 - delphi procedure
Aim: practical applicability
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+
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figure 2 - results of the different components in the development of the rAdboud indicators 
for PAlliative care needs
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Thirdly, a modified Rand Delphi process was performed to select those indicators that are 
appropriate and useful in general practice.44 GPs with palliative care expertise were invited 
to participate in this written procedure, and each was asked to propose another GP with no 
special interest and expertise. They were asked to rate each concept indicator on a nine-
point Likert scale with regard to timing (appropriate to determine the moment at which 
patients might benefit from starting proactive palliative care) and usefulness in general 
practice. Scales ran from 1 = extremely inappropriate/extremely unuseful to 9 = extremely 
appropriate/extremely useful. Additionally, they had the opportunity to refine the descrip-
tion of each concept indicator. After the first round, median ratings, as well as personal 
ratings of each concept indicator were calculated and sent back with the invitation to rate 
and respond to the indicators again. The rounds were repeated until consensus was 
reached. The study ran from December 2007 to August 2008.
Analyses
All focus group sessions were audio-taped, transcribed, and analysed. Analysis of the Delphi 
process was based on the Rand Appropriateness Method.45 Median ratings of each concept 
indicator with respect to usefulness ‘for appropriate timing’ and ‘in general practice’ were 
calculated. Criteria for keeping a concept indicator in the final set were: (1) median rating ≥7 
for as well appropriateness as usefulness, and (2) difference between maximum and mini-
mum rating ≤4 in the second Delphi round.44,46,47 The summary statistics were fed back to the 
participants at each round, along with their initial ranking. The analyses were performed 
using SPSS (version 16.0). 
results
Figure 2 represents the results of the different components in the development of the 
RADboud indicators for PAlliative Care needs (RADPAC). 
Focus group interviews
In total, 25 experts participated in the focus group interviews in which the potential indica-
tors were discussed: five GPs, five medical specialists (a cardiologist in the focus group 
about CHF, two lung specialists in the focus group about COPD, and two oncologists in the 
focus group about cancer), four nursing home physicians, four psychologists, one nurse 
practitioner, three nurses, one priest, and two theologians. The main reason for rejecting 
indicators was the limited clinical utility of indicators in general practice. Rejected indica-
tors were not used in the Delphi process. 
Delphi process
Thirty-eight GPs were invited to participate in the modified Rand Delphi process, 15 of 
whom accepted, 11 with and four with no special interest or expertise in palliative care. 
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Responses were received from seven of the first type of GPs and three GPs from the other 
category. All respondents agreed to be involved in the second Delphi round as well. In the 
second round, eight out of 10 responded, consisting of seven GPs with special interest and 
expertise and one GP without. The RADPAC indicators presented in Table 1. For all diseases, 
a Karnofsky score of 50% or lower appeared to be an indicator. Also, signals given by the 
patient that the end of life is near, or a diminished ‘drive to live’ were considered important 
signs for all three diseases. Weight loss was rated high for COPD and cancer and, conversely, 
gaining weight for CHF. Additional indicators for COPD were the presence of CHF, orthopnoea 
and dyspnoea. With regard to CHF, a New York Heart Association (NYHA) IV score, frequent 
hospital admissions, and frequent exacerbations of severe heart failure were included. For 
cancer, having a primary tumour with poor prognosis and the anorexia-cachexia syndrome 
were considered relevant signs.
table 1 - the rAdboud indicators for PAlliative care needs (rAdPAc) 
Congestive 
heart failure 
1.  the patient has severe limitations, experiences symptoms even while at rest.  
 Mostly bedbound patients. (nYHA iV)
2.  there were frequent hospital admissions (>3 per year)
3.  the patient has frequent exacerbations of severe heart failure (>3 per year)
4.  the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%)
5.  the patient’s weight increases and fails to respond to increased dose of diuretics 
6.  General deterioration of the clinical situation (oedema, orthopnoea, nycturia,  
 dyspnoea) 
7.  the patient mentions ‘end of life approaching’ 
Chronic  
obstructive  
pulmonary  
disease
1.  the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
2. the patient has substantial weight loss (±10% loss of bodyweight in six months)
3.  the presence of congestive heart failure 
4.  the patient has orthopnoea 
5.  the patient mentions ‘end of life approaching’ 
6.  there are objective signs of serious dyspnoea (decreased dyspnoea d’effort,  
 dyspnoea with speaking, use of respiratory assistant muscles and orthopnoea)
Cancer 1. Patient has a primary tumour with a poor prognosis 
2. Patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
3.  there is a progressive decline in physical functioning
4.  the patient is progressively bedridden
5.  the patient has a diminished food intake 
6.  the presence of progressive weight loss
7.  the presence of the anorexia-cachexia syndrome (lack of appetite, general  
 weakness, emaciating, muscular atrophy) 
8. the patient has a diminished ‘drive to live’
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disCussion
Summary
This study developed the RADPAC: three comprehensive sets of indicators to help GPs iden-
tify patients with CHF, COPD, or cancer in need of palliative care. A three-step procedure 
was used, including a literature review, focus group interviews with input from the multi-
disciplinary field of palliative healthcare professionals, and a modified Rand Delphi process 
with GPs.
Strengths and limitations 
Review of literature in this new field was carried out thoroughly, but as indicators are not 
a MESH term, proxies of this term had to be used. For the focus groups, a purposive sampling 
strategy and thus a variety of expertise and experience in palliative care and general practice 
was captured. The knowledge and experience of those GPs who took part in the Delphi 
process was not measured, although we did include GPs with special training in palliative 
care as well as GPs with no special interest.
Whether the RADPAC will support GPs in the early identification of patients who might 
benefit from palliative care is unknown. RADPAC is under study in a randomised controlled 
trial (RCT) including 158 GPs in the Netherlands. Data on this study will be published sepa-
rately. The RADPAC was developed for use in general practice. The different professionals 
who participated in the expert panel sessions reflect the multidisciplinary approach of 
palliative care. The involvement of GPs in the focus group interviews and in the Delphi 
process increases the chance that the RADPAC will be used in general practice.48
Comparison with existing literature
Several lists are available that encourage physicians to identify patients who could benefit 
from palliative care.20,49-51 However, this study is the first to present indicators of the pallia-
tive care trajectory developed from a combined practice experience and scientific evidence 
base. Despite different development strategies, RADPAC has much in common with the 
prognostic indicator guide of the Gold Standards Framework (GSF-PIG).33 In the UK, the GSF 
has been adopted by many GPs and seems to have value in daily practice to improve end-of-
life care.52 The GSF-PIG was developed by consulting different professional representatives 
while RADPAC used a three-step procedure. Yet both approaches have resulted in very 
similar indicators, which strengthen their validity. As RADPAC and GSF-PIG were developed 
in different health care settings, it may also indicate that both instruments address generic 
palliative care guidance for general practice.
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The three sets of indicators in the RADPAC might improve different aspects of palliative 
care. A recent study showed that GPs who are aware of the patient’s preferred place of 
death tend to have a palliative care goal and use palliative care services more often.16 The 
need for timely exploration of care preferences and a focus on palliative care in order to 
improve its quality was important. Early introduction of palliative care for patients with 
lung cancer appeared to improve quality of life and survival time.53 Early identification 
creates more opportunities for better symptom management and communication about 
the full content of palliative care and end-of-life care, such as preferred place of death and 
advanced care planning. GPs who used advanced care planning reported a higher percentage 
of death at home,54 positively enhanced patients’ hope.55 
RADPAC is not intended to be a strict calculator. It has been developed to consider starting 
palliative care in patients at an earlier stage in highly prevalent chronic and life-threatening 
diseases. This study have provided the GPs concrete sets of indicators to consider whether 
the patient has ‘palliative care needs,’ besides diagnosing and treating their current health 
problems. As specific indicators developed for the identification of palliative care patients 
in a hospital setting will not be applicable in primary care, the emphasis in the selection of 
indicators lies in the usefulness and applicability in primary care. Indicators like hypercapnia 
for patients with COPD,56 hyponatremia for CHF,57,58 and percentage lymphocytes for 
patients with cancer35,38 are not useful for early identification in general practice and have 
not therefore been selected. Despite its explicit invitation to consider ‘early identification 
of palliative patients’, the RADPAC still identifies rather late in the illness trajectory. This 
might be explained by the fact that when this research started, early identification in the 
Netherlands was not common practice. Although ‘early identification’ was explained by 
text and Figure 1, participants may still struggle with concepts like ‘end-of-life’ care, ‘pallia-
tive care’ and ‘terminal’ care. As health care systems, insights, and procedures change over 
time, the RADPAC should be updated.
The RADPAC contains solely somatic indicators. Although GPs known for their holistic 
approach, and also a psychologist and spiritual caregiver, were represented in the focus 
group panel, they may have been influenced by the medical specialists and by the given 
input of literature. The decision to identify a patient as in need of palliative care could be 
influenced by other factors than medical ones, such as culture, attitude, and moral ideas of 
a society, financial recourses and restrictions. This multifactorial character of the decision, 
combined with the subjective professional view, may mean that the RADPAC and the GSF-PIG 
is not sufficient enough to standardize this decision. 
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Implications for practice and research 
This study, developing the RADPAC, is the first scientific study to translate an important 
part of the WHO definition for palliative care, namely early identification, to clinical practice 
in a scientifically sound way. The RADPAC can help GPs identify palliative care patients 
within their larger population of patients with CHF, COPD, or cancer. Applying the RADPAC 
is an opportunity to enable proactive care and thus improve the quality of primary palliative 
care. The validity and effect of the RADPAC will be further investigated in an RCT to inves-
tigate whether early identification and proactive palliative care planning coordinated by 
the GP will help improve the quality of palliative care. These results will be published sepa-
rately. As the RADPAC only contains somatic indicators, special attention will be devoted to 
other domains, such as psychosocial, financial and spiritual domains, in an update.
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table 4 - Possible indicators after literature search
Copd indicator number of studies literature
1 Age 16 1,6,7,12,18,20,24,26,29,31,32,33,34,42,44,46
3 level of dyspnoea 8 1,5,6,8,11,13,25,33
4 Peak Vo2 
low Pao2
1
9
1
6,9,15,22,32,33,36,40,44
5 FeV1 <30%
other lung function parameters
15
6
1,4,6,7,9,10,11,12,15,24,25,31,34,44,46
20,30,31,32,45,47
6 cor pulmonale
cardiovascular problems
10 1,8,9,10,11,15,16,7;22,48
7 co-morbidity
dM
7
1
4,10,19,20,24,29,48
20
8 Health status
exercise capacity (6 min walk distance)
At best able to walk a few steps 
Bed to chair functional status
Adl dependency
Home care after discharge
Being house bound
disability
5
9
2
1
1
1
1
2
1,5,7,12,20
1,5,6,10,12,25,28,35,45
9,11
15 
22
22
4
2,47
9 Weight loss 
low BMi
Anorexia
Fat-free mass index
8
14
1
2
1,7,8,9,11,17,20,29
4,6,12,19;24,25,31,34,36,38,39,40,45,47
10
38,42
10 long term o2 therapy 8 2,4,7,8,9,10,11,47
11 readmission
Hospital admission for a severe exacerbation 
(2-3 admissions in last year)
time elapsed since first hospitalisation 
length of hospital stay
4
11
1
2
2,5,22,29
4,7,9,10,11,15,18,19,20;24,33 
40
2,42
12 depression 6 2,4,10,21,27,43
13 low quality of life 4 2,4;24,48
14 surprise question: would i be surprised if my patient 
were to die the next 12 months
3 4,7,10
15 low self esteem 1 5
16 Fatigue
other symptoms
1
1
5
48
17 Frequent exacerbation 5 7,11,24,41,48
18 Paco2
Arterial blood gas
6
2
8,9,11,15,18,35
1,31
19 unresponsive to bronchodilators 2 9,11
20 resting tachycardia >100 2 9, 11
21 Patient makes a choice for comfort care 1 10
22 >6 weeks of systematic steroids for coPd in the  
preceding 12 months
oral corticosteroid use
2
1
10,18
39
23 Polycythemia 1 15
24 Albumin 3 22,35,40
25 sexe 4 24,26,36,42
26 care of professional(s) 2 26,29
27 Haemoglobin 1 31
28 crP 1 37
29 Midthigh muscle cross sectional area
Quadriceps strength
2
1
1,14
34
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Cancer indicator number of studies literature
1 Performance status
Karnofsky performance status
self–care
Patient mobility at admission
Ambulation
Activity of daily living
6
7
1
1
1
1
121,127,128,131,133
123,124,10,125,129,140,142
135
143
135
139
2 Fatigue 2 121,127
3 Headache 1 125
4 Abdominal pain 1 125
5 Anorexia
Weight loss
intake
4
4
1
125,126,129,140
125,126,137,141
135
6 nausea 1 125
7 Vomiting 1 125
8 dysphagia 4 125,126,137,139
9 Xerostomia 1 126
10 drowsiness 
level of consciousness
1
1
125
135
11 confusion 1 125
12 delirium 2 126,139
13 depression 1 121
14 Anxiety 1 121
15 dyspnoea 6 121,125,126,129,139,140
16 use of strong analgesics 1 121
17 Brain metastases 
number of metastatic sites 
Metastatic solid cancer receiving no  
systematic chemotherapy
cancer which is metastatic or not amenable 
for treatment
liver metastases
1
1
1
2
1
121
123
124
10,136
141
18 leucocytosis 4 121,126,129,140
19 lymfocytopenia
lymphocyte percentage
3
2
126,129,141
127,140
20 lactate dehydrogenase 3 121,127,141
21 crP
Vitamin B(12)/c reactive protein index
1
1
126
132
22 Age 5 123,125,128,136,138
23 serum albumin 3 123,127,141
24 edmonton symptom assessment symptom 
score 
Physical symptoms
1
2
123
127,142
25 Kind of tumour 4 128;131,138,141
26 Ascites 1 124
27 Patient with advanced disease makes a choice 
for comfort care only 1 10
28 Gender 2 125,131
29 clinician’s prediction of survival
estimated median survival in days
estimation of the physician
surprise question: would i be surprised if my 
patient were to die the next 12 months?
5
1
1
1
126,129,143,140,141
135
121
10
30 Activity level of disease evidence
Malignant pleural effusion
Malignant bowel obstruction
1
1
1
135
124
124
31 number of admissions to the hospice 1 143
32 living with a spouse 1 131
33 Heart rate >100/min 1 134
34 respiratory rate >24/min 1 134
35 Quality of life 1 142
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Chf indicator number of studies literature
1 Gender 13 49,52,54,60,65,68,74,75,77,78,96,102,114
2 Age 21 49,50,52,54,1,58,60,65,67,68,72,74,75,77,93,97,99,102,1
06,114,115
3 BnP 11 50,60,65,67,72,84,89,92,93,115,116
4 lVeF
lVeF <20% 
lVeF <30%
lVeF <40%
17
6
1
1
50,51,52,53,56,59,60,65,67,68,72,76,77,84,93,114,115
56,8,22,9,15,11
75
1
5 Peak o2 consumption 6 50,51,52,56,76,78
6 Medicine: Ace, B-blocker, spironolacton
Medicine: isosorbidedinitraat, antiarrhytmica, 
statine
optimally treated including afterload reduction
5
1
3
50,60,68,75,77
15
56,9,11
7 nYHA
nYHA iV
nYHA iii-iV
10
5
4
51,54,67,68,74,92,105,111,114,115
56,9,61,72,11
15,77,10,97
8 complex ventricular rhythm
Arrhythmia
dysrrhythmia, therapy resistant
Atrial fibrillation
Permanent pacemaker
3
1
1
3
2
22,1,11
8
59
77,93,97
52,68
9 discharge from hospital
readmission within 2 months
recent cardiac hospitalisation
Hospitalisation
Frequent er visits for symptoms
Hours of hospital presentation
2-3 acute care admits for HF in the past year
1
1
3
7
3
1
1
49
22
54,59,77
56,15,65,78,88,99,114
56,8;10
67
9
10 Activities of daily living dependency >3
reduced functional capacity
exercise capacity (6 min walk test)
Karnofsky score <50%
disability score 
Homecare after discharge
Worse health related quality of life 
Health status
Frailty (frailty staging system)
1
2
5
1
1
1
1
3
1
22
59,67
53,51,60,76,95
56
76
22
69
76,98,110
113
11 Weight loss of 2.3 kg or more within 3 months
loss >10% body weight
low BMi
cachexia
1
2
7
2
22
56,78
60,65,76,93,94,101,114
59,67
12 Albumin
Albumin level <20%
1
1
65
22
13 Anaemia 15 58,59,60,65,67,68,75,77,90,93,97,104,107,118,119
14 Hyponatremia 12 51,52,57,58,59,65,67,68,75,76,77,106
15 troponine 1 65
16 systolic blood pressure 19 54,56,57,1,58,59,15,65,67,68,75,76,77,78;79,102,106, 
112,114
17 respiratory rate 3 58,65,67
18 co-morbidity (dM, Mi, coPd, dementia, HiV,  
peripheral arterial disease, cardiac arrest,  
syncope, cVA)
17 52,57,8,58,59,67,72,74,75,77,78,11,91,97,99,106,114
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Chf indicator number of studies literature
19 dyspnoea at rest
symptoms of heart failure 
orthopnoea
self perceived symptoms
Physical symptoms despite optimal therapy
Fatigue
3
2
2
1
1
1
8,15 ,117
76,11
60,117
60
11
117
20 Higher heart rate 7 54,56,60,65,75,76,78
21 renal failure
creatinine
urea nitrogen concentration
erythropoietin level
9
8
12
2
56,67,72,73,78,87,93,97,102
54,60,65,68,75,77,67,115
57,58,59,67,75,77,86,99,103,106,108,115  
80,85
22 ischemic aetiology 
cause of heart failure
severe valvular disease
cardiomyopathie
4
1
1
3
56,68,72,106
76
77
52,53,114 
23 insurance 
social economic situation
Minority of ethnic group
race
living alone
1
1
1
1
1
65
74
72
65
74
24 depression
depression/Anxiety
Psychological symptoms despite optimal  
tolerated therapy
7
1
1
67,74,78,82,83,100,120
76
10
25 no adherence to medication 1 73
26 surprise question: would i be surprised if my  
patient were to die the next 12 months 2 54,10
27 cardiac norephinephrine spill over
Plasma norepinephrine level
2
1
50,67
67
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Abstract
Background
According to the World Health Organisation, patients who can benefit from palliative care 
should be identified earlier to enable proactive palliative care. Up to now, this is not common 
practice and has hardly been addressed in scientific literature. Still, palliative care is limited 
to the terminal phase and restricted to patients with cancer. Therefore, we trained general 
practitioners (GPs) in identifying palliative patients in an earlier phase of their disease 
trajectory and in delivering structured proactive palliative care. The aim of our study is to 
determine if this training, in combination with consulting an expert in palliative care 
regarding each palliative patient’s tailored care plan, can improve different aspects of the 
quality of the remaining life of patients with severe chronic diseases such as chronic 
obstructive pulmonary disease, congestive heart failure and cancer.
Methods/Design
A two-armed randomised controlled trial was performed. As outcome variables we studied: 
place of death, number of hospital admissions and number of GP out of hours contacts.
Discussion
We expect that this study will increase the number of identified palliative care patients and 
improve different aspects of quality of palliative care. This is of importance to improve pal-
liative care for patients with COPD, CHF and cancer and their informal caregivers, and to 
empower the GP. The study protocol is described and possible strengths and weaknesses 
and possible consequences have been outlined. The Netherlands National Trial Register: 
NTR2815
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BaCkground
According to the World Health Organisation (WHO) palliative care is ‘an approach that 
improves the quality of life of patients and their families facing the problems associated 
with life-threatening illness, through the prevention and relief of suffering by means of 
early identification and impeccable assessment and treatment of pain and other problems, 
physical, psychosocial and spiritual’.1 A first challenge evoked by this definition is the early 
identification of a patient who may benefit from palliative care. Although the WHO-recom-
mendations have been accepted worldwide, no scientific papers have been published yet on 
how to identify patients who could potentially benefit from an earlier start of a palliative 
care in general practice. A literature review of Qaseem et al. did not identify any validated 
tools that predict the optimal timing to initiate palliative care services in general practice,2 
despite the fact that a lot of research has been undertaken to elucidate the prediction of 
mortality, survival, and prognostication for patients with advanced cancer and non-cancer 
diseases.3-10 For patients not recognised as being in a palliative phase an individualised well-
considered plan of action is missing 11,12
Several illness trajectories have been described for people with progressive chronic ill-
nesses.13,14 For none of these trajectories the right moment to start palliative care has been 
defined yet. Particularly regarding patients with non-malignant diseases, such as advanced 
chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF), recog-
nising or defining the moment when palliative care should be taken in consideration seems 
difficult (Figure 1).15,16 In a national questionnaire among multiple palliative care providers 
the lack of prognostic indicators and clinical triggers for starting end-of-life care appeared 
to be the most important missing link in applying palliative care in primary care.17 By inte-
grating palliative care into curative care practices or combining palliative care with disease-
time
death  
Karnofsky-score
Palliative care 
Follow-up care 
informal  
caregiver
intensity ‘interfererence’
general practitioner 
High
low
diagnosis stable phase terminal phase 
Moment of identification
?       ?      ?
figure 1 - What is the moment to start palliative care? a modified figure of lynn and Adamson59
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oriented management earlier in the disease trajectory, chronically ill patients nearing the 
end of life reported improved satisfaction with care and demonstrated less acute interven-
tions and were more likely to die at home.18,19
The second challenge in bringing the WHO definition into clinical practice, for which early 
identification is a prerequisite, is a structured proactive palliative care planning. Palliative 
care programs appeared to reduce symptom distress and improve patient and family satis-
faction. Important elements of structured proactive palliative care proved to be coaching 
the patient to make choices regarding future interventions or restrictions,20-22 consulting 
caregivers,18 eliciting values and addressing the psychological , existential and social con-
text of patient and informal caregiver.23,24 By proactive planning death at home could be 
enhanced,25-27 the number of unforeseen transfers decreased,28 hospital lengths of stay and 
aggressive interventions diminished and consequently costs and utilisation decreased.28-30
For GPs a structured proactive palliative care planning is a challenge, as patients with an 
advanced chronic disease are often under supporting care of the disease-specific specialists 
until far in the disease trajectory.31 The GPs should pick up their role as coordinator of pal-
liative care against the mainstream of disease-oriented interventions.32,33 Several studies 
concluded that when a GP is part of a team, palliative care improves on different aspects; 
for patient, informal carer and the participating GP.34,35
aiMs of the study
Research questions
In this study we aim to answer the following questions: 
Does early identification and proactive palliative care planning of palliative patients by the 
GP influence
1.  Place of death, number of transitions and number of contacts with the out of hours 
primary care service?
2.  Quality of life of patients and their informal caregivers and prescriptions?
3.  GP satisfaction with the delivered palliative care and their own assessment of their 
ability to provide palliative care?
The objective of this report is to present the study protocol used for the data collection in 
2009 and 2010. We describe the protocol of the study, provide a description of the interven-
tion, the methodology and the baseline characteristics of the participating GPs. The described 
methodology will also serve as a reference for future publications about this study.
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Methods/design
Study design
We performed a two-armed randomised controlled trial.
We studied the following hypothesis: H0: training GPs in early identification of palliative 
care patients and proactive care planning will not increase the percentage of patients that 
die at home, will not reduce the amount of hospital admissions and will not reduce the 
number of contacts with the out of hours primary care service. This hypothesis will be 
rejected if the training has a significant positive effect on these aspects of care.
Power calculation
Sample size was based on number of contacts with the out of hours primary care service. 
To detect a difference between the intervention and the control group with a power of 80% 
and an alpha error of 0.05 minimum sample size was 96 patients in both groups when 20% 
reduction in out of hours contacts was considered.
Participants
GPs in two comprehensive cancer centre (IKO and IKZ) regions in the South-East of the 
Netherlands were invited by mail to participate in the study. After one month a reminder 
was send to non-responders. Excluded were GPs who are consultant in palliative care or 
who are locum. GPs that wanted to participate were stratified for degree of urbanisation and 
working hours (part-time or full-time) and were randomised assigned to the intervention 
or the control condition by an independent statistician. To prevent contamination, those 
GPs working together in the same practice were placed in the same study group.
Ethical considerations
The study was conducted after approval of the research ethics committee of the Radboud 
University Nijmegen Medical Center in accordance with the Medical Research Involving 
Human Subjects Acts (WMO). Patient and physician anonymity was guaranteed throughout 
the registration and data entry process. Patients and their informal caregiver were invited 
to participate by their GP. If they agreed to participate in the longitudinal study they received 
a patient information letter and an informed consent form. Trial registration has been 
obtained. (The Netherlands National Trial Register: NTR2815)
The intervention 
The intervention for the GPs in the experimental condition consisted of three consecutive 
parts. 
85incentiVe And MetHods oF An rct
table 1 - the rAdboud indicators for PAlliative care needs (rAdPAc) 
Congestive 
heart failure 
1. the patient has severe limitations, experiences symptoms even while at rest.  
 Mostly bedbound patients. (nYHA iV)                                                                                                                                              
2. there were frequent hospital admissions (>3 per year)
3. the patient has frequent exacerbations of severe heart failure (>3 per year)
4. the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%)
5. the patient’s weight increases and fails to respond to increased dose of diuretics 
6. General deterioration of the clinical situation (oedema, orthopnoea, nycturia,  
 dyspnoea) 
7. the patient mentions ‘end of life approaching’ 
Chronic  
obstructive 
pulmonary 
disease
1. the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
2. the patient has substantial weight loss (±10% loss of bodyweight in six months)
3. the presence of congestive heart failure 
4. the patient has orthopnoea 
5. the patient mentions ‘end of life approaching’ 
6. there are objective signs of serious dyspnoea (decreased dyspnoea d’ effort, 
 dyspnoea with speaking, use of respiratory assistant muscles and orthopnoea)
Cancer 1. Patient has a primary tumour with a poor prognosis 
2. Patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
3. there is a progressive decline in physical functioning
4.  the patient is progressively bedridden
5.  the patient has a diminished food intake 
6.  the presence of progressive weight loss
7.  the presence of the anorexia-cachexia syndrome (lack of appetite, general  
 weakness, emaciating, muscular atrophy) 
8. the patient has a diminished ‘drive to live’
Part one consisted of a five-hours training in early identification of palliative patients and 
proactive care planning. This training was provided by two experienced GPs with a speciali-
zation in palliative care and an extended experience in teaching. Early identification was 
based on two tools, developed in an earlier stage of the project and described elsewhere.36 
The first tool is a plasticised card (Table 1) with indicators to identify and recognise patients 
with respectively COPD, CHF and cancer as being in a stage that palliative care should be 
considered, the so-called ‘Radboud Indicators Palliative Care needs’ (RADPAC). GPs were 
trained in 1) checking actual problems of the patient in a structured way at the moment of 
identification, 2) considering potential problems that could be expected in the (near) future 
and 3) foretelling the most likely scenarios on deterioration and death. A previously devel-
oped tool (Table 2) could be used as an abstract of the content of the training and could be 
used to structure the discussion with the patient and their informal caregiver, and to explore 
their actual and potential problems and needs (Proactive Palliative Care Planning Card 
(PPCPC)). The aim was a shared proactive policy to deliver specific, proper and individualised 
palliative care planning.
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The second part of the intervention consisted of a coaching session for the GPs with a phy-
sician specialised in palliative care regarding each identified patient included in the study. 
In this session the GP received feedback and suggestions on the proposed proactive palliative 
care plan, potential future problems and potential scenarios of deterioration and death.
The third part of the intervention consisted of two peer group sessions of the intervention 
GPs, eight and ten months after the initial training session. In these sessions the main focus 
was patient-GP communication techniques regarding having the first conversation with 
the patient about palliative care (and thus about end-of-life issues). GPs also had the opportu-
nity to exchange experiences on this topic. Data for process description were collected 
during the first year after T0. Effect evaluation took place in April 2011.
Control group
GPs in the control group were asked to provide usual care. They were not trained and had 
no access to RADPAC, nor to the PPCPC. Consultation by telephone with the palliative care 
table 2 - reminder for proactive planning and disease specific potential problems  
(Proactive Palliative care Planning card, PPcPc).
somatic domain social en financial domain 
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems : 
expected problems: 
scenario of dying: 
expected problems: 
Care provision and activity of daily living existential and psychological domain 
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems:
expected problems: expected problems:
possible future problems 
Pain       dyspnoea       ileus       delirium     Fear      depression      coma     liver/renal failure  
strain of informal caregiver                          special technical care 
disease specific interest 
cHF : anaemia     deactivation defibrillator     weight 
coPd: medical /non-medical possibilities against dyspnoea 
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helpdesk of the Comprehensive Cancer Centre was possible as usual. This service is available 
24/7 for all GPs in the two comprehensive cancer centres regions in the South-East of the 
Netherlands; mostly these consultations are on problems in the terminal phase for which 
the GP needs specialised advice for acute problems. For GPs in the control group a training 
will be organised after the intervention study is closed.
Data collection 
At the start of the study (t=1), GPs in the intervention group were asked to use RADPAC to 
screen the medical records of all patients in their practice to identify patients with COPD, 
CHF or cancer who potentially could benefit from a palliative care approach. They were 
instructed to continue to use RADPAC each time new data of a patient with CHF, COPD or 
progressive cancer was available. In 2011, anonymous data were collected retrospectively 
from the medical records of all patients that had a non-acute death during the intervention 
period, as well in the intervention as in the control practices (t=2). All deceased patients who 
were diagnosed with CHF, COPD and/or cancer were included (Figure 2). Each non-planned 
(out of hour) contact and hospital or nursing home admission during the study was derived 
from the medical record and registered as well as place of death and if the patient had been 
identified as being in the palliative trajectory. Besides, qualitative data were collected con-
cerning proactive care planning in both study groups.
Outcomes 
GPs of both study groups were invited to extract data of all patients that died during the 
observational period from the medical records: demographics, disease history, place of death, 
hospital admissions and out of hours consultations. Of each participating GP, demographic 
characteristics, practice characteristics and their interest in palliative care were collected 
(Table 3).
intervention GP
control GP
t=1
identified palliative patient
not identified palliative patient
Moment of
identification
Moment of
identification
death
death
extraction of medical records of patient 
Questionnaire GPs
t=2
figure 2 - study design randomised controlled trial 
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table 3 - Baseline characteristics participating GPs# (n=133)
Characteristics of general practitioners 
Age – yr 48,2  ±  8,1
Gender  male sex – no. (%) 81 (60,9)
Working week   fulltime – no. (%)  70 (52,6)
experience – no. (%)  
 ≤ 1 year 2 (1,5)
   2 - 5 years 14 (10,5)
   6 - 10 years 21 (15,8)
   ≥ 10 years 94 (70,7)
  Missing 2 (1,5)
interest in palliative care* 8,14 ± 1,12
  Missing 3 
estimation of own capability** 6,83 ± 0,92
  Missing 3 
 
Characteristics of practice 
Practice form – no. (%)
  single-handed 28 (21,1)
  dual 53 (39,8)
  Group and health centres 52 (39,1)
  Missing 0
degree of urbanisation – no. (%)
  Very  46 (34,6)
  Moderate 28 (21,1)
  less 41 (30,8)
  no 18 (13,5)
  Missing 0
size of practice  Fte-average practice+  1728 ± 409
  Missing 1 
palliative care
Palliative patients/y – no. (%) 
 ≤ 2 patients 10 (7,5)
 3 - 5 patients 72 (54,1)
 5 - 9 patients 43 (32,3)
 ≥ 10 patients 6 (4,5)
  Missing 2 (1,5)
use of consultant palliative care – no. (%)
   Yes 105 (78,9)
   no 25 (18,8)
   Missing 3 (2,3)
# Plus-minus values are means ±sd. 
+ size of practice = fulltime-equivalent/average practice (= 2350 patients).
* interest in palliative care, visual analogue scale, rang 0, indicating no interest, to 10 very much interest.  
** estimation of own capability, visual analogue scale, rang 0, indicating not capable, to 10 very much-
capable.
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Data management and plan of statistical analysis
All data were entered in a database and analysed with SPSS 16.0. In both study groups, all 
patients who died during the inclusion and observation period of the study of a non-acute 
death, were included in the retrospective analysis. Intervention and control group will be 
compared on the main outcomes (place of death, number of transitions and out of hours 
contact, amount of identified patients). Recruitment rates and drop-out rates will be cal-
culated. In case denominators prove to be significantly correlated with the outcome of the 
main study question, an Anova will be performed to identify potential related or independent 
factors. Multilevel analysis will be performed. 
disCussion
The present study has been designed to assess the effects of training GPs in early identifica-
tion and a proactive palliative care approach regarding patients with COPD, CHF or cancer.
Strengths
Up to now, hardly any data are available about implementing the 2002 WHO-definition for 
palliative care. To our knowledge this is the first intention to treat RCT that assesses the 
effect of training GPs in early identification and using a proactive holistic palliative care 
approach, which are the main aspects of this definition. The training for the GPs in the inter-
vention group was standardized and piloted, to minimize differences between the two 
trainers and to be available for future courses. The tools that the GPs in the intervention 
group could use for helping to identify palliative patients in an earlier stage than usual and 
to structure the proactive care planning, were developed in a scientifically sound way. 
Results will be published in peer-reviewed scientific journals and will be communicated to 
relevant clinician associations. 
Weaknesses 
Those GPs that were interested to take part in the study, probably have a special interest in 
palliative care. Besides, as there is a lot of attention for proactive palliative care in medical 
journals and in Dutch policy, GPs in the control group might be influenced by new informa-
tion or followed courses. This implies that it might be difficult to find significant differences 
between intervention and control group. As patients were identified by their own GP, we 
were not able to influence this process directly. 
We did not choose to collect prospective patient data in the control group, as this would be 
a sort of intervention. Therefore, effect measurement took place retrospectively. GPs in 
both intervention and control group were asked to collect retrospective data from their 
digital patient information system. This implies that we do not have patient data of non-
responding GPs.
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We performed a multifaceted intervention: a combination of training GPs and offering them 
tools to facilitate early identification and proactive care planning. Usually, multifaceted 
interventions are more effective than single interventions,37 but the relative impact of each 
component of the intervention cannot be established.
ConClusion
The present study will increase the knowledge about the effect of training GPs in early 
identification and a proactive palliative care approach. This knowledge is of importance to 
improve palliative care for patients with COPD, CHF and cancer and their informal caregivers, 
as well as to empower the GP. Here, the study protocol is described and possible strengths 
and weaknesses and possible consequences have been outlined. 
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Abstract
Background
Most patients with advanced cancer, debilitating COPD or congestive heart failure (CHF) 
live at home. General practitioners (GPs) asked for guidance in how to recognise patients in 
need of palliative care in a timely way and to structure anticipatory care. For that reason, 
we developed a training for GPs in identifying patients in need of palliative care and in 
structuring anticipatory palliative care planning and studied its effect on out-of-hours 
contacts, contacts with their own GP, hospitalisations and place of death.
Methods
We performed a cluster randomised controlled trial. GPs in the intervention group were 
trained in identifying patients in need of palliative care and anticipatory care planning. 
Next, for each identified patient, they were offered a coaching session with a specialist in 
palliative care to fine-tune a structured care plan. The GPs in the control group did not 
receive training or coaching, and were asked to provide care as usual.
After one year, characteristics of patients deceased of cancer, COPD or CHF in both study 
groups were compared with mixed effects models for out-of-hours contacts (primary out-
come), contacts with their own GP, place of death and hospitalisations in the last months of 
their life (secondary outcomes). As a post-hoc analysis, of identified patients (of the inter-
vention GPs) these figures were compared to all other deceased patients, who had not been 
identified as in need of palliative care.
Results
We did not find any differences between the intervention and control group. Yet, only half 
of the trained GPs (28) identified patients (52), which was only 24% of the deceased patients. 
Those identified patients had significantly more contacts with their own GP (B 4.5218; 
p < 0.0006), were less often hospitalised (OR 0.485; p 0.0437) more often died at home 
(OR 2.126; p 0.0572) and less often died in the hospital (OR 0.380; p 0.0449).
Conclusions
Although we did not find differences between the intervention and control group, we found 
in a post-hoc analysis that those patients that had been identified as in need of palliative care 
had more contacts with their GP, less hospitalisations, and more often died at home. We 
recommend future controlled studies that try to further increase identification of patients 
eligible for anticipatory palliative care. 
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BaCkground  
In developed countries cancer, cardiovascular diseases and respiratory diseases are the main 
causes of death.1,2 Each year, in the Netherlands, about 140,000 persons die and two third of 
them die non-acutely of one of these three diseases.3 Particularly in advanced stages of 
these diseases, symptom burden is high.4-6
In order to improve the care for patients with incurable, life-limiting diseases, the WHO 
stated in 2002 that palliative care should be initiated in an early phase of the disease. A timely 
start facilitates anticipatory care planning in order to meet patient wishes and needs, to 
relieve symptoms and to prevent future symptoms and problems. Regardless of the WHO 
recommendation, palliative care is often restricted to a reactive approach and to the relief 
of physical symptoms in the terminal phase, often resulting in emergency visits by the 
general practitioner (GP),7 unplanned transfers8,9 and hospital admissions.10,11 Consequently, 
too many patients die in another place than preferred, often with ineffective, costly and 
unwanted interventions.12-14
Anticipatory care planning by earlier identification of the needs of patients in an advanced 
stage of their disease appeared to improve the quality of their remaining life, to decrease 
the number of aggressive futile interventions and depressed mood and even to prolong life 
in patients with advanced cancer.15-17
Identification of patients who can benefit from anticipatory palliative care alongside or 
instead of disease-oriented therapies, is challenging particularly in patients with chronic 
obstructive pulmonary disease (COPD) or congestive heart failure (CHF), due to the fact that 
the course of these disease trajectories is difficult to predict.18-22 In addition, these patients 
often don’t realise that they have a limited life expectancy.23 In order to facilitate the iden-
tification of patients at risk of deterioration or dying, and thus for anticipatory palliative 
care, several sets of indicators have been developed, such as the Supportive and Palliative 
Care Indicators Tool (SPICT) in Scotland, the Prognostic Indicator Guide (PIG) in England, 
Neccesidades palliativas (NECPAL) in Spain and the Radboud indicators for Palliative Care 
needs (RADPAC) in the Netherlands.24 These tools contain general or disease-specific indi-
cators of decline. Examples of these indicators are repeated hospital admissions, weight 
loss, decrease in functional status, and the surprise question (Would you be surprised if this 
patient were to die in the next twelve months?).
In the Netherlands patients are registered with a doctor’s general practice, as part of their 
health care insurance. This structures a relation with a personal GP, who provides care for 
the large majority of their health problems presented and is the gatekeeper to specialist and 
hospital care. Through this structure, GPs have an overview and often intimate knowledge 
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of the patient and his/her health conditions and social environment. This primary care-
based structure plays an important role in coordinating early palliative care. GPs consider 
palliative care an attractive and essential part of their task, but experience difficulties with 
timely initiation and their coordinating role in palliative care.25,26 
For those reasons, we developed a training for GPs in using a previously developed set of 
identification indicators, the RADPAC,27 in planning and providing structured anticipatory 
palliative care and in communicating end-of-life issues with the patient. We expected that 
this training would improve the care for palliative patients with cancer, COPD or CHF in the 
form of less contacts with the out-of-hours hours primary care cooperative, a decreased 
number of hospitalisations in the last three months of life, an increased number of con-
tacts with their own GP in the last month of life and an increased number of patients that 
would die at home. We tested this in a cluster randomised controlled trial (RCT). 
Methods
Design
A clustered, two-armed RCT was performed, with the GP as cluster. The study ran from 
February 2009 until February 2011. 
Participants 
All GP practices in two regions of the comprehensive cancer centres of the Netherlands 
were invited by mail to participate. GPs were excluded if they were a consultant in a pallia-
tive care team. Participating GPs were stratified for working hours (part-time or full-time) 
and for degree of urbanisation of their general practice (urban or rural) and they were 
randomly assigned to the intervention or control group by an independent statistician. To 
prevent contamination, GPs working together in the same practice were allocated to the 
same study group. Borland C software was used to randomly allocate GPs, as sequentially 
numbered containers, to the strata of one of both groups.
Intervention
The intervention, described in detail elsewhere,28 consisted of three consecutive parts: 
1. a five hour group training in early identification of those patients in their practice that 
can be considered as being palliative patients, by means of the RADPAC,27 and in proactive 
care planning, 2. an individual coaching session by phone with a physician specialised in 
palliative care, per identified palliative patient for the GP and 3. two additional peer group 
sessions with the GPs in the intervention group a few months after start of the interven-
tion, with a focus on patient – GP communication regarding the initiation of a palliative care 
100 PriMArY outcoMes oF An rct
trajectory. The GPs in the intervention group were invited to use the RADPAC indicators to 
screen the medical records of all persons in their practice to identify those patients with 
CHF, COPD or cancer who potentially could benefit from a palliative care approach. They 
were also asked to use this screening instrument whenever new data of any patient with 
one of these three diseases became available, in order to timely identify the change from a 
curative to a palliative trajectory. They were asked to consider and start structured anticipa-
tory palliative care for every identified patient. The GPs discussed palliative care and the study 
with the patient, and provided him or her a brochure with information about palliative 
care, the content of the study and what participation would imply for the patient. 
GPs in the control group were asked to provide care as usual. Although this usual care differs 
per GP, they all have easy access to a large number of palliative care standards,29 and each 
physician and nurse in the Netherlands can consult a specialist in palliative care 24/7 by 
phone.30
Data collection 
At baseline, demographics and practice characteristics of each participating GP were col-
lected, as well as their interest in palliative care (on a numeric rating scale (NRS) from 0, not 
interested at all to 10, extremely interested) and their confidence in providing palliative 
care by themselves (NRS from 0, not confident at all to 10, extremely confident). 
If the patient was interested to participate, the GP asked him or her to sign an informed con-
sent form, which was faxed to the researcher, together with a questionnaire with charac-
teristics of the patient. The consulted palliative care specialists were asked to register each 
coaching session that they had with the GPs.
After 12 months, GPs that had not yet identified any patients for proactive palliative care 
were phoned by the research assistant and were asked in the form of an open question what 
the reason for non-inclusion was.
One year after start of the study, a questionnaire was sent to each GP in as well the interven-
tion as the control group. They were asked to provide anonymous data, collected from the 
medical records of all patients that died in the past 12 months. This data included whether 
or not the patient died a sudden death, cause of death, age, gender, number and type of con-
tacts with the GP out-of-hours service (by phone, consultation at the service, home visit) in 
the last three months before death, number and type of contacts with their own GP in the 
last month before death (phone calls and home visits during office hours and phone calls 
and home visits during out of office hours), place of death and number of hospital admis-
sions in the last three months of life. Regarding out-of-hours contacts and contact with 
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their own GP we chose a limited period of respectively one and three months before death, 
as we considered this a feasible period to check the electronic medical record, and as such 
contacts are most frequent near the end of life.
Statistical analyses 
The primary outcome measure was the number of contacts with the out-of-hours GP coop-
erative. We estimated that with 96 patients in each group, the study would have an 80% 
power to detect a significance between the intervention and control group, which would be 
a 20% reduction of out-of-hours contact.28
Statistical analysis was performed with the use of SPSS software, version 20.0 and with SAS 
software, version 9.2. Descriptive statistics were used to calculate frequencies, means, and 
standard deviations of the study variables. Differences between GPs in baseline character-
istics were assessed with the use of chi-square tests for categorical variables and Student’s 
t-tests for continuous variables. To study differences, between deceased patients in both 
study groups, mixed effects models were used (SAS GLIMMIX), with the GP as a cluster. In 
this model, the type of disease the patient died of, the age of the GP, working hours, interest 
in palliative care, and estimation of the GP’s own capacity were included in the model as 
possible confounders. 
It appeared that only a portion of the deceased patients had actually been identified as in need 
of palliative care in the intervention group. Therefore we performed a post-hoc analysis. 
We also used the same model to study differences between those patients that had been iden-
tified as in need of palliative care by GPs in the intervention group, and all other deceased 
patients (in as well the control and the intervention group). 
results
Within a period of one month, 159 GPs positively responded to the invitation to participate. 
(Figure 1) After stratification, they were randomly assigned to the intervention (n=80) or 
control group (n=79). For various reasons, 22 GPs in the intervention group were not able 
to join the training course. A majority of these 22 GPs worked fulltime (60%), had slightly 
less years of experience (20% had 0-5 years), worked in a group or health centre (50%), and 
had a larger patient list (2684 patients). Yet, the estimated number of palliative patients in 
this group was lower (only 23.8% estimated to have 5 or more palliative patients per year).
Additionally, one GP from the intervention group and 2 GPs from the control group were 
excluded because they were already trained in specialised palliative care. For those reasons, 
57 GPs received the RADPAC indicators and the training and 77 GPs were considered as 
control group. (Figure 1)
102 PriMArY outcoMes oF An rct
Of the 57 GPs that received the initial training, 28 GPs also followed the two additional peer 
group sessions. 
The characteristics of trained GPs in the intervention and GPs in the control arm did not 
differ in mean age, gender, working hours, years of experience and use of a consultation 
service for palliative care. Also their interest in palliative care and the estimation of their 
own capacity to provide palliative care was the same in both groups. (Table 1) Fewer GPs in 
the intervention arm worked in single-handed practices. The degree of urbanisation of 
their practice was about the same in both groups, as well as the size of their patient list. 
figure 1 - enrolment, follow up and analyses of GPs 
Assessed for eligibility (n=1800)
declined to participate (n=681)
non response (n=960)
Assigned to control (n=79)
Follow-up control (n=77)
Analysed control (n=39)
Assigned to intervention (n=80)
Follow-up intervention (n=57)
Analysed intervention (n=38)
excluded from analysis: (n=23)
- specialised in pall care (n=1)
- not trained (n=22)
lost to follow up (n=1)
discontinued participation (n=8)
non response (n=10)
excluded from analysis: (n=2)
- specialised in pall care (n=2)
lost to follow up (n=3)
discontinued participation (n=12)
non response (n=23)
randomisation (n=159)
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table 1 - GP and practice characteristics
intervention
(n=57)
Control
(n=77)
age mean (sd) 48.54 (7.92) 47.85 (8.16)
Male gender n (%) 36 (63.2) 45 (58.4)
working hours n (%)
Fulltime 29 (50.9) 41 (53.9)
Parttime 28 (49.1) 35 (46.1)
years experience n (%)
0 - 5 6 (10.7) 10 (13.2)
6 - 10 11 (19.6) 10 (13.2)
≥10 39 (69.6) 56 (73.7)
interest in palliative care1 mean (sd) 8.21 (0.92) 8.09 (1.18)
estimation of own capacity to provide palliative care2 mean (sd) 6.80 (0.92) 6.85 (0.93)
Practice type n (%)
single-handed 9 (15.8) 19 (24.7)
dual 28 (49.1) 26 (33.8)
Group or health centre 20 (35.1) 32 (41.6)
urbanisation degree n (%)
High 21 (36.8) 26 (33.8)
Moderate 9 (15.8) 19 (24.7)
low 18 (31.6) 23 (29.9)
no 9 (15.8) 9 (11.7)
patient list mean (sd) 1710 (412) 1730 (417)
estimated number of palliative patients/year n (%)
≤2 4 (7.1) 7 (9.2)
3 - 5 29 (51.8) 43 (56.6)
5 - 9 20 (35.7) 23 (30.3)
≥10 3 (5.4) 3 (3.9)
1 interest in palliative care: numeric rating scale (nrs) from 0 (no interest at all) to 10 (extremely interested) 
2 estimation of own capability: nrs from 0 (not capable at all) to 10 (extremely capable)
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table 2 - Patients who died of cancer, coPd or cHF during the intervention period
intervention
(n=216)
Control
(n=271)
Age in years (mean (sd) 73.0 (14.7) 74.0 (13.1)
Male sex n (%) 106/202 (53%) 144/258 (56%)
primary diagnosis n (%)
   cancer 152/216 (70%) 178/271 (66%)
   cHF 32/216 (15%) 52/271 (19%)
   coPd 26/216 (12%) 20/271 (7%)
   combination of cancer, coPd, cHF 6/216 (3%) 21/271 (8%)
Contact(s) with out-of-hours gp service last 3 months n (%) 114/209 (55%) 157/268 (59%)
By phone   0.79 (2.6) 0.80 (1.5)
consultation at service 0.06 (0.3) 0.09 (0.5)
Home visits 0.85 (1.6) 1.14 (2.2)
Total 1.70 (3.3) 2.03 (2.9)
Contact(s) with own gp last month n (%) 188/212 (89%) 250/268 (93%)
By phone office hours 2.33 (2.9) 2.71 (3.0)
Home visits office hours 5.59 (5.1) 4.42 (3.6)
By phone out of office hours 0.19 (0.7) 0.10 (0.5)
Home visits out of office hours 0.46 (1.1) 0.38 (1.1)
Total 8.58 (7.5) 7.62 (6.0)
location of death n (%)
Home 103/210 (49%) 124/267 (46%)
Hospital 67/210 (32%) 78/267 (29%)
nursing home 13/210 (6%) 16/267 (6%)
care home 12/210 (6%) 21/267 (8%)
Hospice 14/210 (7%) 25/267 (9%)
other location 1/210 (1%) 3/267 (1%)
hospital admission(s) last 3 months n (%) 116/210 (55%) 159/255 (62%)
hospital admissions last 3 months mean (sd) 0.82 (0.9) 0.89 (0.9)
data are mean (sd) or n/n (%). some percentages do not sum to 100% because of rounding. 
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table 3 - Mixed effects model estimating the effect of intervention 
B1 95% Ci p
Number of contacts with out-of-hours GP service last 3 months
0.4828 -0.733 – 1.698 0.4307
cause of death2 0.4599
   cHF -0.1016 -0.806 – 0.603
   coPd -0.4729 -1.403 – 0.457
   combination 0.6775 -0.515 – 1.870
GP works fulltime 1.0229 -0.181 – 2.227 0.0946
Age of GP3 -0.0792 -0.155 – 0.003 0.0418
interest in palliative care3 -0.8286 -1.461 – 0.196 0.0110
self-efficacy regarding palliative care3 0.3191 -0.384 – 1.022 0.3679
Number of contacts with own GP last month
intervention group 0.7155 -0.935 – 2.366 0.3901
cause of death2 <.0001
   cHF -3.8582 -5.434 – 2.283
   coPd -5.0800 -7.173 – 2.987
   combination -4.1761 -6.883 – 1.470
GP works fulltime -1.1778 -2.803 – 0.447 0.1526
Age of GP3 -0.0035 -0.108 – 0.101 0.9474
interest in palliative care3 0.3770 -0.477 – 1.231 0.3813
self-efficacy regarding palliative care3 -0.6855 -1.649 – 0.278 0.1602
intervention group
or4 95% Ci p
Hospitalisation(s) last three months yes/no
intervention group 0.797 0.464 – 1.372 0.4078
cause of death2 0.0132
   cHF 0.729 0.423 – 1.256
   coPd 2.300 1.056 – 5.011
   combination 3.165 1.092 – 9.172
GP works fulltime 0.917 0.539 – 1.561 0.7467
Age of GP3 1.017 0.983 – 1.053 0.3207
interest in palliative care3 0.802 0.606 – 1.061 0.1202
self-efficacy regarding palliative care3 1.227 0.895 – 1.682 0.1993
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or4 95% Ci p
Dying at home yes/no
intervention group 1.130 0.646 – 1.976 0.6655
cause of death2 <.0001
   cHF 0.393 0.227 – 0.682
   coPd 0.174 0.075 – 0.405
   combination 0.167 0.059 – 0.472
GP works fulltime 1.359 0.784 – 2.356 0.2697
Age of GP3 0.995 0.960 – 1.030 0.7644
interest in palliative care3 1.109 0.833 – 1.477 0.4721
self-efficacy regarding palliative care3 0.776 0.558 – 1.079 0.1295
Dying in hospital yes/no
intervention group 1.095 0.684 – 1.754 0.7012
cause of death2 0.0009
   cHF 1.501 0.862 – 2.611
   coPd 3.692 1.870 – 7.292
   combination 2.617 1.102 – 6.217
GP works fulltime 0.863 0.541 – 1.376 0.5303
Age of GP3 0.991 0.962 – 1.021 0.5468
interest in palliative care3 1.021 0.800 – 1.303 0.8654
self-efficacy regarding palliative care3 1.254 0.936 – 1.680 0.1271
1 B = difference of means
2 cause of death (cancer, cHF, coPd or combination of those; cancer is reference group), age of GP, 
working hours, interest in palliative care, and estimation of own capacity were included in the model 
as possible confounders
3 effects of continuous variables are assessed as one unit offsets from the mean
4 or = odds ratio
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table 4 - difference between those patients that were identified as in need of palliative care 
and all others
deceased patients who 
were identified as in  
need of palliative care
(n=49)
deceased patients  
without those  
identified
(n=428)
age mean (sd) 64.8 (12.1) 74.6 (13.7)
Male sex n (%) 30/49 (61%) 219/409 (54%)
primary diagnosis n (%)
cancer 42/49 (86%) 287/436 (66%)
cHF 2/49 (4%) 82/436 (19%)
coPd 4/49 (8%) 41/436 (9%)
combination of cancer, coPd, cHF 1/49 (2%) 26/436 (6%)
Contact(s) with out-of-hours gp service  
last 3 months n (%)
24/47 (51%) 247/430 (57%)
By phone   1.26 (4.9) 0.74 (1.4)
consultation at service 0.04 (0.2) 0.08 (0.4)
Home visits 0.64 (1.1) 1.05 (2.1)
total 1.94 (5.2) 1.88 (2.8)
Contact(s) with own gp last month n (%) 45/49 (92%) 393/431 (91%)
By phone office hours means 3.14 (3.8) 2.47 (2.8)
Home visits office hours means 8.27 (6.7) 4.55 (3.8)
By phone out of office hours 0.46 (1.2) 0.11 (0.5)
Home visits out of office hours 1.02 (1.7) 0.35 (1.0)
total mean 13.00 (9.8) 7.48 (6.0)
location of death n (%) 
Home 33/49 (67%) 194/428 (45%)
Hospital 7/49 (14%) 138/428 (32%)
nursing home 5/49 (10%) 24/428 (6%)
care home 0/49 (0%) 33/428 (8%)
Hospice 4/49 (8%) 35/428 (8%)
other location 0/49 (0%) 4/428 (1%)
hospital admission(s) last 3 months n (%) 20/48 (42%) 255/417 (61%)
hospital admissions last 3 months mean (sd) 0.60 (1.0) 0.89 (0.9) 
data are mean (sd) or n/n (%). some percentages do not sum to 100% because of rounding. 
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Of the 57 trained GPs in the intervention group, 28 GPs identified 52 patients (0.91 per GP; 
0-4) and in 33 cases the GP had an individual coaching session with the specialist in pallia-
tive care by phone (0.58 per GP).
Twenty-nine GPs in the intervention group did not identify any suitable patient for proac-
tive palliative care. Reasons for not having included any patients, as mentioned by the GPs 
during a phone call, were having had no patients that met the RADPAC indicators, difficulty 
initiating an appropriate discussion on proactive palliative care, or rapid deterioration or 
death immediately after having communicated palliative care with the patient. 
Seventy-seven of the 134 GPs (57%) returned the questionnaire with retrospective data of 
deceased patients: 38 of the 57 GPs (67%) in the intervention group and 39 of the 77 GPs (48%) 
in the control group. In total, data from 622 deceased patients was retrieved, of which 487 
(78%) died of cancer, COPD or CHF or a combination of these.
In the intervention (I) and control (C) group comparable numbers of patients per GP died 
of cancer, CHF or COPD within the past 12 months (I:5.7; C: 6.9). Mean age of the patients 
(I: 73; C: 74) was the same as well as the gender distribution (male patients: I: 53%; C: 56%).
The primary diagnosis of the deceased patients was cancer (I 70%; C: 66%), followed by CHF 
(I: 15%; C: 19%), COPD (I: 12%; C: 7%) or a combination of these diseases (I:3%; C: 8%). (Table 2)
In the mixed model analyses, we found intra cluster coefficients (ICCs) from 0.04 (dying at 
home) to 0.14 (out-of-hours contacts). We found no differences between the intervention and 
control group in the number of contacts with the GP out-of-hours cooperative in that last 
three months, nor in the number of contacts a patient had with their own GP in the last month, 
hospitalisations in the last three months, dying at home or dying in the hospital. (Table 3) 
There was a relation found between the cause of death and the number of contacts that the 
patient had with their own GP within the last month of life (p < 0.0001). (Table 3) For patients 
with cancer, the number of contacts in the last month of life with their own GP was higher 
than for patients with CHF, COPD or a combination of these diseases. Cause of death was also 
related to having had at least one hospitalisation in the last three months of life (p 0.0132). 
Patients with COPD were more often hospitalised, as well as those patients with a combina-
tion of these diseases, while patients with CHF had smaller odds to be hospitalised. Finally, the 
cause of death was related to dying at home (p < 0.0001), and to dying in the hospital (p 0.0009). 
Patients with cancer died more often at home and less often in the hospital than patients 
with one of the other causes of death.
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table 5 - Mixed effects model estimating the effect of being identified as in need of pallia-
tive care
B1 95% Ci p
Number of contacts with out-of-hours GP cooperative last 3 months
identified patients -0.0832 -1.156 – 0.989 0.8695
cause of death2 0.4831
   cHF -0.1240 -1.833 – 0.585
   coPd -0.470 -1.404 – 0.464
   combination 0.6421 -0.553 – 1.837
GP works fulltime 1.0132 -0.164 – 2.190 0.0904
Age of GP3 -0.0776 -0.152 - -0.003 0.0410
interest in palliative care3 -0.8049 -1.422 - -0.188 0.0113
self-efficacy regarding palliative care3 0.3545 -0.328 – 1.037 0.3033
Number of contacts with own GP last month 
identified patients 4.5218 2.336 – 6.707 0.0006
cause of death2 <0.0001
   cHF -3.5003 -5.054 - -1.947
   coPd -4.8675 -6.920 - -2.815
   combination -3.9826 -6.633 - -1.332
GP works fulltime -1.3109 -2.865 – 0.243 0.0970
Age of GP3 -0.0008 -1.101 – 0.099 0.9876
interest in palliative care3 0.4259 -0.387 – 1.238 0.2993
self-efficacy regarding palliative care3 -0.8122 -1.730 – 0.105 0.0817
intervention group
or4 95% Ci p
Hospitalisation(s) last three months yes/no
identified patients 0.485 0.215 – 0.975 0.0437
cause of death2 0.0117
   cHF 0.682 0.395 – 1.179
   coPd 2.227 1.017 – 4.879
   combination 3.105 1.074 – 8.973
GP works fulltime 0.939 0.557 – 1.583 0.8094
Age of GP3 1.018 0.984 – 1.054 0.2937
interest in palliative care3 0.792 0.603 – 1.041 0.0935
self-efficacy regarding palliative care3 1.241 0.912 – 1.688 0.1663
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or4 95% Ci p
Dying at home yes/no
intervention group 2.126 0.974 – 4.643 0.0572
cause of death2 <0.0001
   cHF 0.418 0.240 – 0.726
   coPd 0.177 0.076 – 0.414
   combination 0.172 0.061 – 0.485
GP works fulltime 1.321 0.762 – 2.291 0.3166
Age of GP3 0.995 0.960 – 1.030 0.7629
interest in palliative care3 1.116 0.839 – 1.483 0.4465
self-efficacy regarding palliative care3 0.761 0.549 – 1.055 0.1000
Dying in hospital yes/no
identified patients 0.380 0.148 – 0.975 0.0449
cause of death2 0.0011
   cHF 1.361 0.781 – 2.371
   coPd 3.867 1.928 – 7.757
   combination 2.423 1.025 – 5.726
GP works fulltime 0.884 0.554 – 1.409 0.5991
Age of GP3 0.989 0.960 – 1.019 0.4619
interest in palliative care3 1.031 0.809 – 1.313 0.8025
self-efficacy regarding palliative care3 1.309 0.980 – 1.748 0.0678
1 B = difference of means
2 cause of death (cancer, cHF, coPd or combination of those; cancer is reference group), age of GP, 
working hours, interest in palliative care , and estimation of own capacity were included in the model 
as possible confounders
3 effects of continuous variables are assessed as one unit offsets from the mean
4 or = odds ratio
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Post-hoc analysis: identified patients versus all other patients
Of the 52 patients that had been identified as in need of palliative care, there were 50 with 
available data; two patients had moved and it was not possible to follow up on their status. 
One patient (with COPD) was still alive at the moment that the retrospective data was col-
lected. Data of the remaining 49 deceased patients was compared to data of all other patients 
from GPs in the intervention as well as the control group (n=437) that died of cancer, COPD 
or CHF or a combination of these.
Table 4 shows that the identified patients were younger than the other patients (64.8 versus 
74.6 years). Also their primary diagnosis differed; the identified patients were more likely 
to have cancer (86 versus 66%), and less often CHF (4% versus 19%). 
The number of contacts in the last three months of life with the out-of-hours GP service was 
the same in both groups. Yet, the identified patients had more contacts with their own GP in 
the last month of life (13.00 versus 7.48). Also the location of death differed: the identified 
patients died at home more often (67 versus 45%) and less often in the hospital (14 versus 
32%). 
Finally, a smaller percentage of the identified patients had had at least one hospitalisation 
in the last three months of their life as compared to the other patients (42 versus 61). The 
mean number of hospital admissions of identified patients was also lower (0.60 versus 0.89).
We found no differences in number of contacts with the out-of-hours GP cooperative in the 
clustered model, controlled for GP clusters, cause of death (cancer, CHF, COPD or a combi-
nation of these), the GP working part-time or fulltime, age of the GP, interest in palliative 
care and self-efficacy regarding providing palliative care. However, there was a difference 
in the number of contacts that identified patients had with their own GP in the last month 
before death (p 0.0006). They were less often hospitalised in the last three months of life 
(p 0.0437), and died less often in the hospital (p 0.0449). Although they also died more often 
at home, this difference was not statistically significant (p 0.0572).
disCussion
This study reports the results of an RCT on the effects of training GPs in early identification 
of patients that could profit from palliative care and in structured anticipatory palliative care 
planning. There was no difference found in the primary outcome: the number of consulta-
tions with the out-of-hours cooperative was the same for the intervention and control 
group. Also no effects were found in the secondary outcome parameters: other types of 
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contact with their own GP, hospital admissions and place of death. Yet, in the intervention 
group only 24% of the patients that died of cancer, CHF or COPD, had been identified as in 
need of palliative care. In addition, only half of the trained GPs actually identified patients, 
and coaching sessions were requested for only a part of patients. For those reasons, we 
performed a post-hoc analysis in which we studied the outcomes regarding those patients 
which had actually been identified by the trained GPs as in need of palliative care in com-
parison to all the other patients from the intervention and control group. The identified 
patients had had more contact with their own GP in the last month of life, had half the 
chance to have a hospitalisation in the last three months of life, had less than half the 
chance to die in hospital, and twice the chance of dying at home, although the latter was 
not statistically significant. Of the identified patients 67% died at home. In a recent study 
concerning place of death of home-dwelling patients that died after a protracted terminal 
illness, 52.5% of the Dutch patients died at home, which is a much lower occurrence than 
of our identified patients.31
The mean age of the identified patients was ten years younger than that of the other patients. 
This may have influenced the place of death, as younger patients are more likely to have a 
partner who can take care of them which may have increased their chance of dying at 
home. Also in an English study, the chance of dying at home or in a hospice was higher for 
younger patients.32 Yet, in a German study, younger patients had a higher chance to die in 
hospital.33 The influence of age on the outcome is therefore unclear.
The positive effects of the intervention regarding those patients that had had anticipatory 
palliative care is in accordance with several other RCTs. In a Canadian nurse-led study, early 
palliative care for patients with advanced cancer had a significant effect on parameters such 
as quality of life and depressed mood.16 However, they did not find an effect on the number 
of hospitalisations. In an American study, Temel et al. found that early palliative care resulted 
in an improved quality of life and mood, less aggressive interventions and prolonged sur-
vival in patients with advanced lung cancer.15 In a cluster-RCT in Canada, Zimmermann et 
al. found a significant improvement in quality of life at the end of life and satisfaction with 
care, but no significant effect on the quality of life as measured with the Facit-spiritual well 
being of advanced cancer patients 3 months after inclusion.17 All three studies were restricted 
to patients with cancer, and in all three studies patients were included via hospitals, in 
contrast to our study. In these studies, the intervention was hospital-based and delivered 
directly to the patients. In our study GPs were included as participants, not patients. We 
provided them with training and tools to identify and proactively plan the care for pallia-
tive patients. 
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Yet, only half of the trained GPs in the intervention group identified patients in need of pal-
liative care, and the identified number per GP was only a fraction of the number of patients 
that died per GP during this period. These aspects indicate an identification problem with 
regard to the RADPAC tool and/or an inclusion threshold. Secondly, and probably related to 
the limited number of identified patients: our intervention addressed GPs, while it is often 
a medical specialist who remains the primary caregiver for patients in their final stage of life. 
This is related to the fact that patients still receive disease-oriented interventions. In such 
cases, training GPs without actively involving the medical specialists will hardly influence 
the identification of palliative patients or palliative care planning. Finally, although GPs are 
the experts in discussing end-of-life aspects with their patients, and our intervention further 
strengthened this expertise, the reality of daily life still is, that timely palliative care and 
involving the patient in anticipating a care trajectory remains difficult, particularly in non-
cancer patients. Seeing as the entire disease trajectory of patients with COPD can span 
15-20 years, and of patients with CHF spans 5-10 years, which is much longer than the 
trajectory of most patients with cancer, changing such a long-term relation will require 
more efforts than just a training on anticipatory palliative care. Janssen et al. described in 
2011 that for several reasons, the quality of communication about end-of-life issues with 
patients with COPD needs to be improved.23 Also in our study, more patients with cancer 
had been included than patients with COPD or CHF. This was also one of the conclusions of 
a review on palliative patient-GP communication.34
Strengths and weaknesses
This is the first RCT to study the effect of training GPs in identifying patients in need of 
palliative care and in providing structured palliative care planning. We were able to include 
many GPs in a very short period of time, which confirms their interest in palliative care.25,26
Although we planned to perform an intention-to-treat analysis, the GPs which were allo-
cated to the intervention group but did not follow the training, were lost to follow up. The 
characteristics of these GPs differed slightly; they were more likely to work fulltime and 
they had a larger patient list. Yet, we do not think that this loss to follow up influenced our 
main findings, as we only found differences in the post-hoc analyses in which the identified 
patients were compared to all other deceased patients. Next, only 57% of the GPs returned 
the questionnaire with patient data, and therefore we could not include their deceased 
patients in the analyses. Thirdly, the positive effects we found regarding those patients that 
had been identified as in need of palliative care, were found in a post-hoc analysis, which 
has not been described in the study protocol. These results need to be explored further in 
future studies, as we don’t know whether these differences are caused by the intervention 
or because the identified patients are a selected group. Lastly, it was not possible to prospec-
tively register and monitor patient data in the control group, and thus of having quality of 
life as outcome measure. 
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ConClusions
This study shows that the design we chose was not completely compatible with an inter-
vention that combined identification of patients in need of palliative care and anticipatory 
care planning. Only a portion of the eligible patients had been identified, and in this sub-
group a post-hoc analysis showed positive effects of having identified patients as in need of 
palliative care and providing anticipatory palliative care. For that reason, the absence of 
differences between the entire intervention and control group does not show a failure of 
anticipatory palliative care; it reflects a low number of identified patients. 
We have used the insights from this study to adapt our methodology and to ensure that 
patients are timely identified as in need of palliative care. These adaptations are currently 
being applied in a prospective study on proactive supportive care in patients with COPD. 
Patients are recruited by the attending specialist at the moment of hospitalisation for an 
acute exacerbation COPD, palliative care is provided by a dedicated hospital palliative care 
team, and the primary outcome is quality of life.35
We thank all GPs and practice assistants who participated in the study and data collection.
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Abstract
Introduction 
To support general practitioners (GPs) in providing early palliative care to patients with 
cancer, COPD or heart failure, the RADboud indicators for PAlliative Care needs (RADPAC) 
and a training were developed to identify such patients and to facilitate anticipatory palliative 
care planning. We studied whether GPs, after 1 year of training, identified more palliative 
patients and provided multidimensional and multidisciplinary care more often than untrained 
GPs. 
Methods
We performed a survey 1 year after GPs in the intervention group of an RCT were trained. 
With the help of a questionnaire, all 134 GPs were asked how many palliative patients they 
had identified, and whether anticipatory care was provided. We studied number of identified 
palliative patients, expected lifetime, contact frequency, whether multidimensional care 
was provided and which other disciplines were involved. 
Results
Trained GPs identified more palliative patients than untrained GPs (median 3 versus 2; 
p 0.046) and more often provided multidimensional palliative care (p 0.024). In both condi-
tions, most identified patients had cancer. 
Conclusions
RADPAC sensitises GPs in the identification of palliative patients. Trained GPs more often 
provided multidimensional palliative care. Further adaptation and evaluation of the tools 
and training are necessary to improve early palliative care for patients with organ failure.
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introduCtion 
Many patients with an advanced stage of cancer or another life limiting disease suffer from 
problems like pain, nausea or a depressed mood.1-3 In several studies from the USA and 
Canada, mainly regarding patients with cancer, early palliative care increased quality of 
life and decreased emotional distress and useless aggressive interventions.4-6 Despite these 
positive findings, palliative care is still often restricted to reactive terminal care and to 
patients with cancer.7 However, not only do existing problems and requirements need to be 
addressed, future scenarios should be considered. Early initiation of palliative care enables 
anticipation of future problems, needs and wishes of patients. 
Also, in the Netherlands, early palliative care is not a part of daily practice. The GP is the 
preferred professional to coordinate palliative care8 as most patients live at home in the 
final phase of their lives. Every person has his or her own gate keeping GP; also, out of 
hours care is arranged via the GP out-of-hours cooperatives, which, in addition, have a gate 
keeping function. GPs consider palliative care as an attractive and important aspect of 
their profession, even though it is demanding and challenging.9,10 However, they consider 
timely identification of patients who can benefit from anticipatory palliative care challenging, 
particularly in patients chronic obstructive pulmonary disease (COPD) or congestive heart 
failure (CHF), as the course of these disease trajectories is difficult to predict.2,11-14 
For those reasons we developed the RADboud indicators for PAlliative Care needs (RADPAC), 
to support GPs in the early identification of those patients with cancer, COPD or CHF that 
might profit from palliative care.15,16 RADPAC contains indicators for GPs, used as triggers to 
identify a need for palliative care in these patient groups. Besides, we developed a specific 
training for GPs on using RADPAC and in how to provide structured anticipatory palliative 
care. The effect of this training was subsequently evaluated in a randomised controlled 
trial (RCT) in which over 130 GPs participated.17 We did not find a difference between the 
patients with cancer, COPD or CHF who died in the year after start of the RCT in any of the 
groups of trained and untrained GPs in contact with the out-of-hours GP cooperative in the 
patients’ final months of life, contacts with their own GP, hospitalisations or place of death. 
However, of those patients of trained GPs that died in the year after the training, only one-
third had been identified by their GPs as being palliative patients. Those patients actually 
identified had had significantly more contacts with their GP (13 versus 7.48/month), had 
undergone less hospitalisations (14 versus 32%), and more often died at home (67 versus 
45%) and less often in hospital (14 versus 32%) than all other deceased patients.17 These 
retrospectively collected outcome measures of deceased patients were limited to short-
term effects , did not provide insights into the palliative care provided, and did not provide 
insights in the effects of the several components of the training. 
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For those reasons, 1 year after start of the RCT, we studied whether trained GPs at that time 
cared for a larger number of palliative patients than the untrained GPs, and whether the care 
provided more often was multidimensional (exploration of somatic, social and financial, 
care giving and activities of daily living, and existential and psychological problems and 
needs) and multiprofessional (different types of health care professionals involved). Finally, 
in the untrained GP group, we studied the short-term effect of providing the RADPAC. 
Methods 
Design
We performed a survey 1 year after start of an RCT, begun 2010, to compare trained (interven-
tion) and untrained (control) GPs as additional, secondary outcomes. 
Ethical procedures
The study was conducted after approval of the research ethics committee of the Radboud 
University Nijmegen Medical Center in accordance with the Medical Research Involving 
Human Subjects Acts (WMO) (registration number 2007/205), and registered in the 
Netherlands Trial Register. (NTR2815)
Participants
In total, 134 GPs who had participated in the RCT 1 year prior received a questionnaire by 
mail in Spring 2011. Of them, 57 GPs (intervention group) had been trained 1 year prior in 
the early identification of their palliative patients using the RADPAC, and in providing 
structured proactive palliative care in their daily practice, while the 77 untrained GPs had 
provided care as usual (control group). 
Intervention the trained GPs had received 1 year prior
One year before this survey, the GPs allocated to the intervention group had undergone a 5h 
group training session in early identification and proactive palliative care planning. During 
this training, they received and practiced with the following tools, developed within our 
research group: (1) the RADPAC, a tool with specific indicators to identify patients with, 
respectively, COPD, CHF and cancer, who might profit of palliative care,16 and (2) a proactive 
palliative care planning card, the ‘problems and needs square’: a tool to make a structured 
proactive care plan in which actual as well as possible future problems (somatic, social and 
financial, care giving and activities of daily living, and existential and psychological), dying 
scenarios and patient’s wishes and needs are considered. The GPs of the trained group were 
invited to apply this knowledge and these tools in their daily practice, and thus to identify 
palliative patients and to make a proactive palliative care plan for each of them. (Appendices 
1 and 2)
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Regarding each identified palliative patient, the trained GPs were offered an individual 
coaching session by phone with a consultant specialised in palliative care. During this 
session, they discussed the anticipatory care plan the GP had prepared, and adapted it if 
needed. Finally, all trained GPs were offered two additional face-to-face peer group sessions 
in which experiences could be exchanged and could practice communicating end-of-life 
aspects on simulated patients.16 The GPs in the control condition had not received any 
training or intervention.
Data collection 
Baseline characteristics, demographics and practice characteristics of the GPs had been 
collected 1 year prior, at the start of the RCT. These were age, gender, fulltime equivalent 
work experience, years of experience as a GP (≤ 1 year, 1-5 years, 5-9 years, ≥ 10 years), their 
interest in palliative care (numeric rating scale (NRS) from 0, no interest at all, to 10, very 
interested) and their self-efficacy in providing palliative care (NRS from 0, no confidence at 
all, to 10, very confident). Also collected was information on the kind of practice (solo, duo 
or group) and the degree of urbanisation of their general practice as well as their mean 
patient list and the estimated number of palliative patients per year.
Effects on the provision of palliative care, 1 year after the training took place 
With the help of a questionnaire, all GPs (trained or untrained) were asked how many pal-
liative patients they currently cared for. They did not receive a definition of palliative care, 
but they did know that the research project concerned identification of and proactive care 
planning for palliative patients with the GP as coordinator. Of each of these patients, they 
were asked to provide gender, age, disease (cancer, COPD, CHF, other), expected remaining 
lifetime (in weeks), their current type and number of contacts with the patient (per month; 
respectively by phone, consultation or home visits); whether a key information summary 
had been handed over to the GP out-of-hours cooperative; which type of problems they had 
explored (somatic, social and financial, care giving and activities of daily living, spiritual and 
psychological aspects; yes/no questions) and the type of other involved disciplines in the 
care for the patient (physiotherapist, spiritual caregiver, social work, medical specialist, 
palliative care consultant, psychologist, nursing aid at home, volunteers; yes/no questions). 
Short-term effects of applying RADPAC 
Three weeks after having received the questionnaire, GPs in the control condition who had 
responded to the first questionnaire were sent the RADPAC, which they had never seen 
before.16 They were asked to complete another, similar questionnaire again, in which they 
could add those palliative patients they recognised as being palliative, after being triggered 
by the RADPAC indicators.
125secondArY outcoMes oF An rct
table 1 - General practitioners and practice characteristics responders and non responders
gps that participated in the rCt  
1 year prior
intervention       
(n=12)
Control  
(n=28)
intervention
(n=45)
Control  
(n=49)
resPonders nonresPonders
age in years mean (sd) 45 (8)                  48 (8) 49 (8) 48 (8)
Male gender n (%) 9 (75.0) 19 (67.9)              27 (60.0) 26 (53.1)
working hours n (%)
Fulltime 5 (41.7) 17 (63.0)              21 (46.7) 25 (51.0)
Part-time 7 (58.3) 10 (37.0)              24 (53.3) 24 (49.0)
years of experience n (%)
≤1 0 (0) 0 (0) 1 (2.3) 1 (2.0)
1-5 2 (16.7) 2 (7.4) 3 (6.8) 7 (14.3)
6-10 2 (17.7) 4 (14.8) 9 (20.5) 6 (12.2)
≥10 8 (66.7) 21 (77.8)            31 (70.5) 35 (71.4)
interest in palliative care1
nrs 0-10 (iQr)
8.0 (0.0) 8.0 (1.0)              8.0 (1.0) 8.0 (2.0)
estimation of self-efficacy in  
palliative care provision2 
nrs 0-10 (iQr)
7.0 (2.0) 7.0 (0.5)               7.0 (0.8) 7.0 (1.0)
practice type n (%)
single-handed 2 (16.7)  9 (32.1)             7 (15.6) 10 (20.4)
dual 7 (58.3) 8 (28.6)             21 (46.7) 18 (36.7)
Group or health centre 3 (25.0) 11 (39.3)             17 (37.8) 21 (42.9)
urbanisation degree n (%)                                    
urban 8 (66.7) 14 (50)                 22 (48.9) 32 (65.3)
rural 4 (33.3) 14 (50)                 23 (51.1) 17 (34.7)
patient list  mean (sd) 3491 (1579)      2787 (1389)      3602 (2101) 3024 (1535)  
estimated number of palliative  
patients/year n (%)                                   
 
≤2 4 (33.3) 13 (46.4)              3 (3.8) 6 (12.2)
3-5 5 (41.7) 11 (39.3)            22 (50.0) 24 (49.0)
6-9 3 (25) 3 (10.7)            16 (36.4) 16 (32.7)
≥10 0 (0)  1 (3.6)                3 (6.8) 3 (6.1)
1 interest  in palliative care: numeric rating scale (nrs) from 0 (no interest at all) to 10 (extremely interested).
2 estimation of self-efficacy: nrs from 0 (not capable at all) to 10 (extremely capable).
GPs, general practitioners; rct, randomised controlled trial.
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Statistical analysis
To study differences between trained and untrained GPs, we analysed, using the data of the 
first questionnaire, the number of palliative patients the GPs were currently aware of and 
their characteristics, as well as the estimated remaining lifetime (mean and % > 4 weeks) 
– whether or not the GP out-of-hours cooperative was informed – the number and type of 
palliative care domains that were considered per patient as well as the percentage of patients 
who had had a multidimensional problem and needs exploration (operationalised as three 
or more domains being explored) and number and type of involved disciplines. Additional 
palliative patient data collected from the untrained GPs after having received the RADPAC 
were not included in these analyses but described separately. 
Statistical analyses were performed with the use of SPSS software, V20.0. Descriptive statis-
tics were used to calculate frequencies, means, and SDs of the study variables. Differences 
between trained and untrained GPs, and between patients of trained and of untrained GPs, 
were assessed with the use of Fisher Exact tests for categorical variables, as some cells 
counted less than 5 and, because of the relatively small number of patients, with the non-
parametric Mann Whitney tests for continuous variables. As these data concerned second-
ary outcomes of an RCT, no power calculation was made.
results 
In total, 12/57 trained GPs (21%) from the intervention group and 28/77 (36%) of the control 
group filled in the questionnaire. Responding trained and untrained GPs had about the 
same mean age (45 and 48 years, respectively; Table 1). Of the trained GPs, 75% were males, 
and of the untrained GPs, 68% were males. Besides, 42% of the trained GPs and 63% of the 
untrained GPs worked fulltime. A lower percentage of the trained GPs had 10 or more years’ 
experience (67 versus 78%). Their interest in palliative care was the same (both NRS 8) as 
well as their self-efficacy in providing it (both NRS 7). Most trained GPs worked in a dual 
practice (58%), and the untrained GPs more often in a solo (32%) or group practice or health 
care centre (39%). Of the trained GPs, 67% worked in an urban region, while this figure 
was 50% for the untrained GPs. The patient list of the practice where the trained GPs 
worked was higher than the list of the practices of the untrained GPs (respectively 3491 
and 2787 patients). Almost all GPs in both groups were estimated to have between 0 and 5 
palliative patients per year (75 and 86%, respectively).
Of the non-responders, the percentage women was higher, they worked in larger practices 
with a longer patient list and more palliative patients. (Table 1)
 
In total, all GPs together had identified 119 (46 plus 73) palliative patients (Figure 1). The 
trained GPs had identified a median of 3 palliative patients, which was significantly higher 
than the median of 2 patients in the untrained group (p 0.046; Table 2).
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table 2 - characteristics of identified palliative patients and palliative care they received
patients of 
trained gps 
(n=46)
patients of  
untrained gps
(n=73)
p
number of identified patients median (min-max)                 3 (2-8) 2 (1-7) 0.046
Age in years median (min-max) 74.5 (39-96) 70 (10-98) 0.064
Male gender1 n (%)
Missing
20 (43.5)
5
35 (54.7)
9
0.544
primary diagnosis1 n (%) 0.630
cancer 34 (75.6) 58 (79.5)
coPd 2 (4.4) 1 (1.4)
cHF 0 (0) 0 (0)
other* 9 (20) 14 (19.2)
expected lifetime weeks median (min-max) 16 (2-100) 20 (1-82) 0.728
expected remaining lifetime ≥ 4 weeks1 n (%)
Missings expected lifetime n (%)
43 (93.5)
3 (7)
47 (64.4)
14 (19)
0.062
Current monthly contact frequency median (min-max) 4 (0-24)   2 (1-36)   0.690
Contact(s) per patient with own 
gp last month ≥ 1 monthly n (%)
By phone office hours 25 (52.1) 19 (27.5) 0.025
By consultation office hours 14 (27.5) 12 (17.6) 0.243
Home visits office hours 41 (80.4) 60 (85.7) 0.739
gp informed out-of-hour service about patient1 n (%) 26 (56.5) 45 (61.6) 0.324
type of dimensions1 n (%) 
somatic
social and financial
Activities of daily living (Adl)
spiritual and psychological
25 (54.3)
7 (15.2)
24 (52.2)
19 (41.3)
39 (53.4)
7 (9.6)
30 (41.1)
17 (23.3)
0.852
0.564
0.455
0.103
number of dimensions median (min-max) 2 (0-4) 1 (0-4) 0.266
number of dimensions1 n (%)
0     dimensions   
1     dimension     
2     dimensions   
≥ 3  dimensions   
20 (43.5)
1 (0.02)
5 (0.3)
20 (43.5)
31 (42.5)
7 (0.1)
20 (43.5)
15 (20.5) 0.024
type of disciplines1 yes (%) 
Physiotherapist
spiritual caregiver
social work
Medical specialist
Palliative care consultant
Psychologist
Home care (nurse)
Volunteers
1 (2)
2 (4)
0 (0)
34 (74)
3 (7)
0 (0)
19 (41)  
2 (4)
7 (10)
5 (7)
2 (3)
49 (67) 
7 (10) 
2 (3)
21 (29)
12 (16)
0.141
0.700
0.515
0.416
0.738
0.515
0.323
0.043
number of disciplines median (min-max) 2 (0-4) 2 (0-5) 0.849
* combination of cHF, coPd and cancer or another disease like dementia, neurological causes or kidney 
failure. data are mean (sd) or n (%). some percentages do not sum to 100% because of rounding.
1 Fisher exact for categorical variables. other p values are Mann Whitney tests.
 cHF, congestive heart failure; coPd, chronic obstructive pulmonary disease; GP, general practitioner.
 Bold indicates statistically significant p-values.
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Of the palliative patients, the median age was about the same in both groups (74.5 versus 
70 years; p 0.064) as well as their gender (44 versus 55% males; p 0.544). In both groups, 
the primary diagnosis was most often cancer (76 and 80%; p 0.630). The category ‘other’ 
diseases (respectively, 20% and 19%) mostly concerned a combination of cancer and CHF, CHF 
and COPD or COPD and cancer. A few times other diagnoses like dementia, amyotrophic 
lateral sclerosis, a cerebrovascular accident, or chronic kidney failure were mentioned.
The median estimated remaining lifetime of the palliative patients was about the same in 
trained and untrained GPs (16 versus 20 weeks; p 0.728). The percentage of expected re-
maining lifetime being ≥4 weeks was non-significantly higher in patients of the trained GPs 
(94% versus 64% of the patients; p 0.062).
We found no significant difference between trained and untrained GPs in the percentage of 
patients of whom the GP out-of-hours cooperative was informed (57 versus 62%; p 0.324). 
The median number of total contacts with their own GP was about the same in both groups 
(4 versus 2; p 0.690). Almost all patients had had at least one monthly contact with their GP. 
The percentage of patients who had had at least one contact by phone was higher in the 
trained GP group (52 versus 28%; p 0.025). The percentage of patients who had had at least 
one monthly consultations did not differ significantly between both groups (28 versus 18%; 
p 0.243), nor did the percentage of patients with at least one home visit per month (80 and 
86%; p 0.739). 
figure 1 - Prisma flow chart of involved GPs and identified palliative patients. 
2nd questionnaire plus rAdPAc
1st questionnaireFirst questionnaire to all GPs that participated in the rct 
1 year prior
(57 trained; 77 untrained GPs)
responding  
trained GPs (n=12)  
identified 46 patients
responding 
untrained GPs (n=28) 
identified 73 patients
untrained GPs 
responding to 2nd 
questionnaire (n=6)
additionally
identified 18 patients
GP, general practitioner; rct, randomised controlled trial; rAdPAc, rAdboud indicators of Palliative 
care needs. 
129secondArY outcoMes oF An rct
table 3 - untrained GPs who completed in 1st and 2nd* questionnaire
untrained 
gp
(n=6)  
identified**  
palliative  
patients 1st   
questionnaire  
(n)
Cancer identified***  
palliative  
patients 2nd   
questionnaire  
(n)
Cancer Copd Chf total  
of  
identified 
patients
(n)
A 1 1 1 1 2
B 1 1 2 1 1 3
c 1 1 2 1 1 3
d 4 4 6 5 1 10
e 3 3 3 3 6
F 1 1 4 2 1 1 5
* in this equal questionnaire, they were asked to mention additionally identified patients, triggered by 
the rAdPAc that they received alongside.
** these GPs only identified those patients with cancer who were mentioned in the first questionnaire.
*** no patients with other diseases than cancer, coPd or cHF were identified by these GPs.
cHF, congestive heart failure; coPd, chronic obstructive pulmonary disease; GP, general practitioner.
The median number of explored dimensions (somatic, social and financial, activities of daily 
living (ADL), and spiritual and psychological) did not differ significantly (2 and 1 respectively; 
p 0.266), but trained GPs more often explored ≥ 3 dimensions (44 versus 21%; p 0.024). In the 
patients of the trained GPs, the spiritual and psychological dimension was twice as often 
explored, but this difference was not significant (41% versus 23%; p 0.103). 
The median number of other involved disciplines was the same in both groups (2; p 0.849). 
In the care of patients of the untrained GPs, volunteers were significantly more often involved 
(4 and 16%; p 0.043). 
Three weeks after the first questionnaire, the untrained GPs who had responded to the first 
questionnaire received the RADPAC, and were asked to use it to complete a similar ques-
tionnaire again, adding patients additionally identified as being palliative. Six untrained GPs 
(6/28 = 21% of the GPs that responded to the first questionnaire)also completed this ques-
tionnaire and became aware of a mean of 3 additional palliative patients (Table 3) . These six 
GPs had already identified a mean of 1.8 patients after the first questionnaire. Of these 18 
patients, 5 patients (28%) had chronic organ failure. 
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disCussion 
One year after start of an RCT in which GPs in the intervention condition were trained in 
identifying their palliative patients and in structured, proactive palliative care, trained GPs 
were aware of significantly more palliative patients in their practice and more often provided 
multidimensional care. With the help of an additional questionnaire a few weeks later, we 
also found that untrained GPs who received the RADPAC identified additional palliative 
patients.16
The percentage of patients with an expected remaining lifetime of ≥ 4 weeks was non-
significantly higher in the trained GP group. However, as we performed a cross-sectional 
study and did not follow-up when these patients actually died, we do not know how long 
the actual survival was and whether the correctness of the estimation differed between 
trained and untrained GPs. Twenty per cent of the untrained GPs did not complete the 
question about the remaining lifetime expectancy, while this figure was only 7% in the 
trained GPs. In the untrained GPs, a prognostic paralysis might have contributed to this 
large number of missings.18 Two other studies also showed that it is hard for GPs to provide 
such figures. 9,19-23
Of the trained GPs, twice as many palliative patients had had a multidimensional problems 
and needs assessment, meaning that at least three dimensions (somatic, social and finan-
cial, ADL, and spiritual and psychological) were explored. Particularly, exploration of the 
spiritual and psychological dimension contributed to this difference. A Dutch study of Van 
der Brandt showed that psychological and spiritual aspects of care need more attention in 
the last days of the dying patients.24-26 Although person-centred, integrated care belongs to 
the core values of GPs and the importance of the bio psychosocial model in the chronic care 
context has been recognised by all relevant Dutch stakeholders, this ideal appeared to be 
poorly embedded8; our results suggest that this is also true for palliative care. This is not a 
surprise, since guidelines and standards as well as reimbursement of care expenditures are 
mainly based on biomedical outcome indicators, ignoring the psychological or spiritual 
aspects.
Most often, the somatic domain was explored by both the trained and untrained GPs. This 
finding is in line with their medical background. However, in contrast to a study by Meijler 
et al., 10 which showed that a workshop in palliative care mainly improved attention and 
knowledge of the somatic dimension, the trained GPs in our study did not differ from the 
untrained GPs in this aspect.27 As the somatic domain was only explored in half of the identi-
fied patients, this also implies that for half of the patients this was not carried out, although 
it is known that many patients with an advanced stage of cancer,1 COPD2 and CHF, suffer 
multiple problems and many patients do not report these problems spontaneously.28,29
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No significant difference between trained and untrained GPs was found in the number of 
disciplines involved in the palliative care of their patients. In about two-third of the patients 
of as well the trained as the untrained GPs, a medical specialist was involved. In many cases, 
palliative patients continue to visit the medical specialist, even when no life prolonging 
treatment options are available anymore. Weeks et al.30 found that many patients with 
incurable cancer receiving chemotherapy did not understand that chemotherapy is unlikely 
to be curative. This wrong perception compromises their ability to make informed treatment 
decisions. It implies that patients often receive treatments too long. Improving interdisci-
plinary collaboration between medical specialist and GP might contribute to shared decision-
making regarding advantages and disadvantages of treatment options. 
The six untrained GPs who responded to the second questionnaire, after having received 
the RADPAC, became aware of a mean of 3 additional palliative patients, which was even more 
than the 1.8 patients they mentioned in the first questionnaire, suggesting that RADPAC 
contributes to the identification of palliative patients. A quarter of these additional palliative 
patients had COPD or CHF, which is a higher percentage than in the first questionnaire of as 
well the trained as the untrained GPs, and more in line with Dutch mortality data of these 
diseases.31
These positive effects indicate that RADPAC might be an answer to the need for tools to 
identify palliative patients in an earlier stage.16,32-34
Strengths and weaknesses 
This is one of the first studies that, using an additional question within an RCT, evaluated 
long-term effects of training in which GPs in the intervention group had been trained in 
identifying patients in need of palliative care and in providing structured, proactive pallia-
tive care.15,16 In this study, we also tried to make a distinction between the effects of the 
RADPAC and those of training in providing multidimensional palliative care.
Unfortunately, the response rate was extremely low. Regarding the trained GPs, the response 
rate was only 21%. Of the untrained GPs, the response rate was 36%, but regarding the 
second questionnaire in this group this figure was also low (21%). Probably mainly the most 
motivated GPs will have responded, which might have influenced the results. Another 
questionnaire regarding the primary and secondary outcomes of the RCT, send to the same 
GPs at the same time and described elsewhere17 resulted in a response rate of 57%, which is 
much higher. An explanation might be that the practice assistant could complete that ques-
tionnaire, which concerned deceased patients, while the questionnaire about current pallia-
tive patients had to be completed by the GP. The trained GPs had completed a considerable 
number of forms during the intervention period, the year before. Voting with their feet as 
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a result of fatigue regarding being asked again to complete a questionnaire, and time invest-
ment of all GPs might have been barriers to completing it.35 The GPs received this question-
naire in the run-up to a national protest action, in which most Dutch GPs signed a manifest 
‘Het roer moet om’ (A change of direction) against the growing workload of administration, 
forms, and obligations.36 This probably will have contributed to the low response rate. 
Another limitation is that we had not asked how many palliative patients the GPs cared for 
at baseline. Owing to this, the low response rate and the fact that these data were secondary 
outcomes that were not used in a power calculation, all findings should be interpreted with 
caution.
ConClusions 
This study shows that a training programme in proactive palliative care provision and in 
using RADPAC to identify palliative patients even 1 year later improves the number of identi-
fied palliative patients. Additionally, multidimensional care, which could, particularly, be 
contributed to more attention given to the spiritual and psychological dimension, was more 
often offered by trained GPs. 
Untrained GPs who 3 weeks after the first questionnaire received the RADPAC and were 
asked to consider their patient list again to identify additional palliative patients, in total 
identified more patients than the trained GPs; and identified a larger percentage of patients 
with COPD or CHF. This indicates that, although a training programme in using the RADPAC 
still positively influences awareness of palliative patients 1 year later, RADPAC seems to have 
the largest effect immediately after applying it, and particularly in detecting patients with 
COPD or CHF in need of palliative care. As RADPAC is restricted to cancer, COPD and CHF, 
we recommend extension with indicators for other life-limiting diseases, like has been 
done in other tools.20
Finally, we recommend an implementation trajectory in which GPs as well as medical 
specialists are involved, in which timely identification of palliative patients is an ongoing 
process.
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appendix 1 - the rAdboud indicators of PAlliative care needs (rAdPAc) 
Congestive 
heart failure 
1.  the patient has severe limitations, experiences symptoms even while at rest.  
 Mostly bedbound patients. (nYHA iV)
2.  there were frequent hospital admissions (>3 per year)
3.  the patient has frequent exacerbations of severe heart failure (>3 per year)
4.  the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%)
5.  the patient’s weight increases and fails to respond to increased dose of diuretics 
6.  General deterioration of the clinical situation (oedema, orthopnoea, nycturia,  
 dyspnoea) 
7.  the patient mentions ‘end of life approaching’ 
Chronic  
obstructive  
pulmonary  
disease
1.  the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
2. the patient has substantial weight loss (±10% loss of bodyweight in six months)
3.  the presence of congestive heart failure 
4.  the patient has orthopnoea 
5.  the patient mentions ‘end of life approaching’ 
6.  there are objective signs of serious dyspnoea (decreased dyspnoea d’effort,  
 dyspnoea with speaking, use of respiratory assistant muscles and orthopnoea)
Cancer 1. Patient has a primary tumour with a poor prognosis 
2. Patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
3.  there is a progressive decline in physical functioning
4.  the patient is progressively bedridden
5.  the patient has a diminished food intake 
6.  the presence of progressive weight loss
7.  the presence of the anorexia-cachexia syndrome (lack of appetite, general  
 weakness, emaciating, muscular atrophy) 
8. the patient has a diminished ‘drive to live’
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appendix 2 - reminder for proactive planning and disease specific potential problems 
(Proactive Palliative care Planning card, PPcPc) - Problems square
somatic domain social en financial domain 
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems : 
expected problems: 
scenario of dying: 
expected problems: 
Care provision and activity of daily living existential and psychological domain
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems:
expected problems: expected problems:
possible future problems 
Pain       dyspnoea       ileus       delirium     Fear      depression      coma     liver/renal failure  
strain of informal caregiver                          special technical care 
disease specific interest 
cHF : anaemia     deactivation defibrillator     weight 
coPd: medical /non-medical possibilities against dyspnoea 
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Abstract
Background
Palliative care is mainly restricted to terminal care. General practitioners (GPs) are not trained 
to early identify palliative patients with cancer, COPD or heart failure. With the help of the 
RADboud indicators for PAlliative Care needs (RADPAC), we trained GPs to identify patients’ 
needs and to make a proactive care plan. They were also able to join two role-plays where 
they discussed the patient’s future, and consulted a palliative care consultant to fine-tune the 
care plan. We evaluated the programme with the GPs and consultants and noted its impact 
on their daily practice. 
Design
Two years after they had participated in the programme, we held semi-structured interviews 
with the GPs and a focus group interview with the consultants and performed a thematic 
content analysis.
Results
Six consultants and nine GPs participated in the programme. Most GPs and consultants 
mentioned positive changes in the thinking or acting of GPs regarding early palliative care. 
A number continued to use the tool to identify patients; most of the others noted they had 
internalised the indicators. Although half of them still considered discussing end-of-life 
aspects difficult, particularly in patients with organ failure, the others were more easily 
able to discuss the future with their palliative patients. 
Conclusion
Although most GPs and consultants were positive about the training programme and apply-
ing it in daily practice, we conclude that in future programmes, more attention needs to paid 
to timely identification of palliative patients with COPD or CHF and how to discuss the future 
with them. 
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BaCkground
Palliative care is an approach that improves the quality of life of patients and their families 
facing the problem associated with life-threatening illness, through the prevention and relief 
of suffering by means of early identification and impeccable assessment and treatment of 
pain and other problems, physical, psychosocial and spiritual.1 This widely accepted WHO 
definition shows that palliative care should not be restricted to reactive symptom relief 
and crises interventions. Timely palliative care makes it possible for the patient, the family 
caregiver and the healthcare professional to anticipate the wishes, future problems and 
terminal scenarios related to the patient’s situation. It improves quality of life and reduces 
depression and aggressive interventions in the last months of life.2-4 However, early pallia-
tive care has not been widely implemented as the optimal starting moment, model, and 
structure are poorly defined. 
In the Netherlands, most patients in their final stage of life live at home and would prefer 
to die there.5 This implies that the general practitioner (GP) should be the coordinator of 
their care. Several studies report on the tools that have been developed to support the GP 
in this specific role: an instrument to help GPs stimulate patient-centred communication;6 
a method to improve interaction between GPs and district nurses;7 and a communication 
training programme for GPs.8
Dutch GPs have requested aids to help them timely identify their palliative patients. 
In response, we developed the RADboud indicators for PAlliative Care needs (RADPAC).9 
(Appendix 1) In addition, we developed the ‘problems square’ to help GPs make a structured, 
multidimensional overview of the patient’s current and future problems, needs, and advance 
care planning (ACP) wishes.10 (Appendix 2) We then trained GPs in identifying their pallia-
tive patients and in delivering structured proactive care. Following the training programme, 
the GPs were also offered a consultation by phone with a consultant specialised in palliative 
care for each identified patient. They were able to discuss the draft multidimensional care 
plan and the communication training with simulation patients.10 We studied the effects in 
a randomised controlled trial (RCT) and found no differences between the intervention and 
control condition in number of contacts with the GP out-of-hours cooperative, hospitalisa-
tions, and place of death. Yet, the GPs only identified a quarter of all the palliative care patients 
who died in the year after the GP training programme. A post hoc analysis showed those 
patients identified by the trained GPs as needing palliative care, were 25% less often hos-
pitalised in the last three months of life, had more contacts with their GP (13 versus 7.5 
contacts), more often died at home (67% versus 45%), and less often died in hospital (14% 
versus 32%).11
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To gain better insights into the practical application of RADPAC and the training programme, 
we explored the views of both the GPs and the consultants who advised the GPs in order to 
fine-tune the proactive palliative care plan, two years after the GPs had been trained. We 
asked them to evaluate the tools, the model, and its application in daily practice.
Methods
Design
A qualitative study nested in the intervention condition of this larger RCT was conducted 
to get in-depth information of how participants evaluated the RCT’s tools and training 
programme.11 We used a combination of focus group methods and individual telephone 
interviews.12
Ethical considerations
This study was part of a research project approved by the Research Ethics Committee of the 
Radboud University Medical Center (2007/205) in accordance with the Medical Research 
Involving Human Subjects Acts (WMO). It also conformed to the Helsinki Declaration.13 
Oral informed consent was obtained from all participants.
Participants
Participants were (1) GPs who had participated in the RCT11 and had been trained in timely 
palliative care two years prior to this study, and (2) consultants in palliative care who had 
specialised post-academic training in palliative care and with whom the GPs discussed the 
concept care plan. The main features of the intervention condition are described in box 1.
Focus group interview consultants
All consultants who had been consulted by any of the GPs trained in timely palliative care 
for a specific patient were invited to participate in a focus group interview. Each of them 
was asked to complete a questionnaire including demographic variables: gender, age, years 
of experience work as a palliative care consultant (fte – full time equivalent), and their other 
profession if they only worked as a consultant part-time.
An interview guide was developed based on the content of the intervention condition and 
extensive discussion within the project team. Using this guide, we explored: (a) experiences 
of the consultants in this new role as timely palliative care consultant; (b) the interaction 
with the GP during the consultations and the identification; and (c) the GP’s proactive care 
planning input. A GP moderated the focus group interview. Those consultants not able to join 
the focus group meeting were asked to participate in a semi-structured interview by phone. 
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Telephone interviews with the trained GPs 
We selected a convenience sample from the group of the 58 trained GPs and asked them to 
participate in a semi-structured telephone interview conducted by a trained female medical 
student. GPs were invited to participate and interviewed until saturation was reached.
The interviewer used a topic list, previously developed by the project team, to explore the 
GPs’ experiences with the training programme in general, identifying palliative patients, 
with the RADPAC9 (Appendix 1) and their anticipatory care planning using the Problems 
Box 1 - Main features of the intervention condition
intervention the trained gps had received two year before
two years prior to this qualitative study, the GPs that had been allocated to the interven-
tion condition of a randomised controlled trial had received a five-hour group training 
in early identification and proactive palliative care planning. during this course, they 
received and practiced using the following tools developed by our research group: 
(1)  the rAdPAc, a tool with specific indicators to identify patients with coPd, cHF 
and cancer who might benefit from palliative care, and 
(2) a proactive palliative care planning card, the ‘Problems square’: a tool designed to 
help users make a structured proactive care plan in which current and possible future 
problems (somatic; social and financial; caregiving and activities of daily living; and 
existential and psychological), dying scenarios, and patient’s wishes and needs are 
considered. 
the trained GPs were invited to apply this knowledge and these tools in their daily prac-
tice, and thus to identify palliative patients and to develop a proactive palliative care 
plan for each of them. With regards to each palliative patient the trained GPs identified, 
they were offered an individual coaching session by phone with a consultant specialised 
in palliative care. during this session the anticipatory care plan the GP had prepared 
was discussed, and adapted where needed. Finally, all trained GPs were offered two 
additional face-to-face peer group sessions in which experiences could be exchanged, 
and where they could practice with simulation patients to communicate end of life 
aspects. 
the GPs in the control condition had not received any training or intervention.
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Box 2 - description of themes and quotes
a the training 
B identification of the palliative patient
1 “(…) regarding patients with CHF or COPD it becomes a hell of a job. And particularly  
when it concerns progress in time, that is also difficult. But when it concerns a patient  
with cancer, you know by and large (…) what is going to happen, and thus how to develop  
a plan.” (consultant)
C Communication with the patient
2 “But when you consider to start discussing end-of-life aspects, then I realise that such  
a message will come across the patient as quite a burden. […] (GP)
3 “I tended to communicate concealed and now I am more straight. (GP)
4 “It is possible to prepare patients, and I am better prepared myself too.” (GP)
5 “More than before, I keep an eye on them (…), people of whom you realise that they will not 
cure anymore, with whom it sooner or later will go wrong, like patients with COPD, CHF, 
that kind of people.” (GP)
6 “It is not just arranging more care, but also assessing what goes wrong or can go wrong  
and how can I anticipate on that (…) which can result in more care provision, but also in 
medication, or checking things.” (GP)
d proactive care planning with the problems square
7 “I mean, as a GP I already did it that way but not as structured as with the problems square. 
And now it is easy to check did I consider all aspects, as it is sometimes mixed up.” (GP) 
8 “I really liked the idea […] to consider prospectively what might occur […] in the several 
segments.”(GP) 
9 “Doing it completely like stated in the protocol asks a lot of time, while many aspects will 
be addressed during the conversation anyhow.” (GP) 
10 “With this kind of things, and that probably also counts for the problems square and the 
RADPAC, there will be a bigger chance that I use it when it is integrated as a protocol in the 
electronic medical record.”(GP)
e Consultant – gp interaction 
- experiences of the consultant
11 “(…), as a consultant, you receive all kind of questions and honestly: I don’t know everything 
from neurology to paediatrics and all other specialties. So, also as a consultant you need 
dare to say: ‘I cannot answer this question, I will consult someone else myself (…).” 
 (consultant)
12 “No, in fact nothing needed to be solved acutely. You could frankly take a helicopter view 
(…).” (consultant)
- the role of the GP
13 “The advantage is, (…) at the moment the GP fills in the problems square and he does it in  
a conscientious manner, than a lot of the potential future problems are already considered, 
just by filling in the form…” (consultant)
14 “The GP has a clear picture of the patient and probably knows him quite well. I, on the  
contrary, only know what has been filled in the problems square.” (consultant)
- interaction between consultant and GP
15 “That is my trick, a bit as when you sit down to table (…) and give people room to talk, than 
you gain a lot more than when you just tick a check box.” (consultant)
- Follow up
16 “And at the same time, I would be curious whether the proactive suggestions you had 
provided (…) had landed and thus if the advice had an added value for the GP and probably 
for the palliative care for that specific patient…” (consultant)
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Square. (Appendix 2) After we received informed consent of each participant, both the focus 
group and individual telephone interviews were audio-recorded and transcribed verbatim.
Data analysis
We used the software programme Atlas.ti 614 for the (Dutch language) thematic content 
analysis. At first, we divided the transcripts into parts that covered the main aspects of the 
training and its application (see A through E, box 2). Within each part, two researchers 
completed the line-by-line coding. They gradually discussed their codes until they reached 
consensus and the agreed codes were used in the consecutive transcripts; where possible, 
overarching themes were deduced. They compared the views from both the perspectives 
of the GPs and the consultants, if applicable. The deductive process, discrepancies and inter-
pretations were regularly discussed within the research team. 
Results 
The group interview took 1.5 hours. Four of the participating eight consultants worked part-
time for one of the Dutch comprehensive cancer centres. Two of them were men and all 
were aged between 41 and 63. They had between 3 to 9 years’ experience as a palliative care 
consultant. One also worked as a GP, one as an elderly care physician, another as a palliative 
care consultant at a Radboud university medical center, and one as a teacher in palliative 
care courses. Two female consultants, a GP and an elderly care physician, were interviewed 
by phone as they had other commitments at the time of the focus group interview. The 
number of consultations per consultant performed within the prospective study varied 
between 1 and 11. 
Of the thirteen GPs invited for interviews, nine were willing to participate; three women 
and six men. Saturation was reached after the seventh interview; during the 8th and 9th 
interview no new themes emerged. 
The mean duration of the interviews was 17 minutes (5-25).
GP evaluation of the training programme
Except for one, all GPs were positive about the training programme: they all mentioned 
positive changes in their thinking or acting as a result. For most GPs, this meant that their 
view on palliative care had changed: they were awakened to the fact that many of their 
chronic patients did not receive palliative care, although it was actually required. The GP 
who reacted less positively stated that he was already aware of what had been taught and 
practiced during the training programme. 
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Identification of the palliative patient with the help of RADPAC
The respondents considered the indicators for timely identification of palliative patients 
with cancer, COPD or CHF to be clear.9 Several GPs mentioned that they had integrated the 
indicators in their daily practice in such a way that they had them in mind and were able to 
use them directly, although others preferred to trust their clinical experience and evaluation 
of the patient. Several GPs still found timely recognition of palliative patients with organ 
failure difficult, despite using the indicators (Box 2, quote 1).
Communication with the patient
When communicating with palliative patients with COPD or CHF, many GPs still found it 
difficult to discuss end-of-life aspects, as many patients do not realise that their condition 
is life-limiting and life threatening (quote 2). With regard to communicating the transition 
from a merely curative to a palliative process with these patients, four GPs did not report any 
changes as a result of the programme. Two of them noted that they had never experienced 
any issues with these conversations, implying that the programme had not helped them. 
Most interviewees stated that they were more aware of, and paid greater attention to iden-
tifying patients with advanced stages of chronic conditions and who might benefit from 
palliative care, (quote 3), and several of them had the impression that communication with 
these patients had improved (quote 4). One of them mentioned paying more attention to 
future problems in the communication with his patients after being trained (quote 5). Some 
GPs observed real differences in how they predicted, communicated about and anticipated 
future problems; they discussed this more regularly and more proactively with their patients 
(quote 6).
Proactive palliative care planning with the Problems Square
In general, the interviewees were positive about the Problems Square (Appendix 2). They 
stated that it helped them consider actual and possible future problems, needs and scenarios 
regarding all dimensions, and it prevented problems being overlooked (quotes 7-8). A few 
GPs still used the plasticised chart with the problems square, but most noted that they no 
longer needed it. The most important reason given for not using the plasticised version was 
time investment in relation to its added value (quote 9). At least three GPs would highly 
appreciate a digital version, integrated in the electronic medical record (quote 10). Another 
GP suggested adding the palliative care plan to the home care file in order to facilitate its 
use. One GP would appreciate an additional heading ‘euthanasia and palliative sedation’ in the 
format, stating that patients often have expectations and wishes regarding these topics, but 
in many cases neither the GP nor the patient raises them. One GP never used the proactive 
care plan at all. 
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Consultant findings 
Experiences of the consultants regarding proactive care planning 
The consultants considered themselves capable of advising GPs on proactive care planning, 
however they also mentioned that their knowledge is limited and would like to have better 
insights into where they can find this missing knowledge (quote 11). They referred to elderly 
care physicians as being most likely to have expertise on palliative care for patients with 
CHF or COPD.
Most consultants agreed that a proactive care consultation takes more time than a standard 
consultation, however, when it is planned and not the result of a crisis, there is more time 
available (quote 12).
The role of the GP, as described by the consultants
Consultants appreciated the GP completing the problems square format prior to the consul-
tation. In these cases, they noted that the GPs were better prepared and had better insights 
into the patient’s situation as well as the current and the potential future problems (quote 13). 
Yet, the accuracy and level of details when completing the problems square varied strongly. 
Often, only one or two ‘catchwords’ were noted which did not give the consultant a clear 
picture of the patient and context (quote 14); one consulted noted that the spiritual dimen-
sion was often left out.
Interaction between consultant and GP
Communication between the GP and consultant was considered to be valuable. The con-
sultants considered themselves as sparring partners when discussing the scenarios and 
found it important to leave room for discussion, as this enabled them to dig deeper into the 
patient’s situation and give more detailed advice (quote 15).
Follow up
All consultants would have liked to have had a follow-up contact with the GP to explore 
which scenario had occurred and to hear what the GP had done with the consultant’s advice 
(quote 16). 
disCussion 
We evaluated the value of the GP training programme in identifying those patients that 
might profit from early palliative care, in communicating the future with the patient, and in 
structuring proactive palliative care. We also evaluated the use of the tools, the consulta-
tions, and how this influenced the care they provide. 
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Most GPs mentioned small changes in attitude and their way of thinking about palliative 
care and how to provide it. It widened their view on palliative care, and made them realise 
that patients with chronic diseases might also benefit from its timely initiation. These 
small changes are in line with the findings from two systematic reviews on educational 
interventions in the field of palliative care that show that education does have an effect on 
self-efficacy and attitude of physicians regarding palliative care, but only a limited effect on 
their daily behaviour.15,16
Although the RADPAC indicators that help GPs become aware of those patients that might 
benefit from palliative care were considered clear, most GPs no longer used the physical 
tool in their daily practice. However, several GPs stated that they had integrated the indi-
cators in their daily practice. They also noted that they still found it difficult to recognise 
patients with organ failure who might benefit from palliative care. Other studies report that 
GPs and medical specialists experience barriers in palliative care provision to patients with 
COPD or CHF;17-19 Dutch patients stated that clinicians rarely discussed life-sustaining treat-
ment preferences, prognoses, dying processes, or spiritual issues with them.19 Many GPs 
would appreciate a digital RADPAC, fully integrated in the electronic medical record system 
as has been developed in Scotland, where it was found to be successful in timely identifying 
palliative patients.20 These findings are in line with the results of our RCT where only half 
of the trained GPs actually identified and reported patients who might benefit from pallia-
tive care. Of all the trained GPs’ patients with cancer, COPD or CHF who died in the year 
following the training programme, only one of four had been identified.11 Of the patients 
who died, a third had COPD and/or CHF, while only 14% had been identified as requiring 
pro-active palliative care. In a study on timely palliative care in patients with COPD,21 a 
clear and ‘natural’ moment to apply this type of tool was noted as being an event like acute 
hospitalisation. 
Some GPs still considered it difficult to start a conversation on anticipatory care with their 
patients with COPD or CHF. This is in line with a study by Janssen et al., which showed that 
most patients with COPD did not realise that they had a life-threatening disease, and that 
many of them do not feel that they are ready to talk about end-of-life issues.19 In addition, 
the disease progress of COPD is often unpredictable, which can substantially hamper GPs 
in shared decision-making about future care options and needs.22 Earlier studies report that 
barriers for end-of-life discussions with patients with organ failure appeared to be lack of 
time and lack of communication skills.19,23 Uncertainty about the course of the disease 
contributes to a ‘prognostic paralysis’, meaning that the GPs do not feel the urge to discuss 
end-of-life aspects with these patients. In contrast, most of the group of interviewees 
mentioned that it was currently easier to communicate, and that this better prepared them 
for proactive care planning in the future. Not all of the GPs interviewed joined the addi-
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tional training sessions in which they could practice communication with simulation 
patients. We expect that those who had practiced with simulation patients who are in 
these kinds of conversations to feel more confident, as role-playing is an effective way of 
increasing communication techniques as well as doctors’ satisfaction about their commu-
nication skills.15,24
With regard to the proactive palliative care planning aspect of the training, most GPs stated 
that the Problems Square was valuable for structuring the inventory of actual and possible 
future problems, needs and wishes. This is in line with the findings of a questionnaire we 
sent to all GPs who participated in the trial, one year after the start of the RCT. Of the 
responding GPs, the trained GPs noted twice as often as the untrained GPs that they had 
conducted a multidimensional problems and needs assessment with the palliative patients 
they had at that moment.25 Only a few still used the plasticised chart; the others said they 
had internalised it.
Consultation
Although the consultants considered themselves capable of being a sparring partner for 
the GPs with regard to proactive palliative care planning, they were unable to answer each 
question. They stated that they needed to know where they could retrieve knowledge them-
selves if in doubt, or when they lacked the expertise; they also admitted needing extra 
training themselves with regard to proactive palliative care for patients with COPD or CHF. 
As we did not record the consultations between GPs and consultants, we cannot objectively 
evaluate how proactive the consultants’ advice was. The fact was noted that an anticipatory 
consultation takes them more time than a ‘normal’ consultation for acute problems in ter-
minal patients. Yet, if anticipatory consultations are planned at a convenient moment, this 
extra time investment was not considered a problem, as it may even prevent acute consul-
tations at a later stage.
The consultants were positive about the preparations the GPs had made prior to the con-
sultation: the GP is the only person who can provide the complete picture of the patient, 
and the consultant is dependent on what the GP mentions. However, the consultants stated 
that the GPs only noted a few catchwords in the Problems Square, and often did not prepare 
the spiritual dimension. Our analysis shows that the combined spiritual/psychological 
dimension was only explored in about 40% of the patients, but this was twice as often as the 
results of a large Dutch prospective study of untrained GPs (paper under review). In this 
study, consultants also appeared to be better able to identify spiritual and psychological 
problems using problem clarification.26 The EAPC taskforce on spiritual care in palliative 
care has the objective of improving this aspect of palliative care.27 In the Netherlands, a 
nation-wide guideline on this subject has been published, of which an English translation 
151PrActicAl APPlicAtion oF tools And A trAininG ProGrAMMe
is available.28 Finally, the consultants would appreciate a systematically planned second 
consultation with the GP about the same patient, to evaluate the effects of their advice.
Strengths and weaknesses
This study provides insights into how those GPs trained in timely identification of patients 
in need of palliative care and in anticipatory care planning, perceived its value after two 
years. Although several studies have evaluated the effects of educational interventions on 
palliative care, the quality of those studies is often poor, and often restricted to short time 
effects.15,16,29 With the help of the results of this qualitative study, future training modules 
in timely palliative care can be adapted to be more in line with GPs’ needs. 
A strong point of this study is the triangulation: we interviewed both the GPs and the con-
sultants. Studying a topic from different viewpoints gives a more complete image of the 
topic and increases its internal validity.30
The study has a number of weaknesses. It became clear that many patients were under care 
of a hospital specialist who did not apply proactive palliative care. This means that the process 
of planning proactive palliative care is challenged; the GP misses natural trigger moments 
to apply RADPAC. Another fact was that our training programme did not provide an instruc-
tion on when to initiate joint primary-secondary care, or when to move back to primary care. 
This hindered identification and proactive care planning.
We used a convenience sample of GPs. In addition, we did not ask the GPs to evaluate the 
consultation, which means that this aspect of the intervention was only evaluated by the 
consultants. Given the range in the number of consultations held by the consultants, those 
with more consultations will have contributed more to the discussion than those who with 
less experience. We did not analyse whether participant demographics like age, years of 
experience or gender, influenced our findings. 
As the interviews took place two years after the initial training sessions, it is likely that the 
GPs would not be aware of exactly what they had learned during the programme and what 
they had learned via other channels in the same period. Another potential weakness is that 
only four consultants took part in the focus group interview, although in the two phone 
interviews held after the group interview, no new information was revealed, indicating that 
saturation had been reached. Finally, we only interviewed a limited number of GPs and con-
sultants, which means that we were unable to find differences regarding socio-demographic 
characteristics of the participating GPs and consultants. 
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ConClusions
Two years after being trained in providing timely palliative care, GPs were still able to men-
tion positive changes in their daily practice. They also noted difficulties initiating palliative 
care with their patients with organ failure, as they were still hesitant to discuss end-of-life 
aspects with these patients. This information has been used to optimise the training pro-
gramme for GPs and consultants in this field. Aspects that required more attention in the 
training programme were (1) the use of a ‘natural’ marking moment such as information 
transfer between primary and secondary care or hospitalisation; (2) how to communicate 
end-of-life aspects with these patients; (3) To pay more attention to completing all the 
domains of the Problems Square, and (4) holding consultations with a palliative care expert 
to discuss and evaluate the proactive care plan.
Finally, we also recommend integrating identification and advance care planning tools in 
the GPs’ electronic medical record system.
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appendix 1 - the rAdboud indicators of PAlliative care needs (rAdPAc) 
Congestive 
heart failure 
1.  the patient has severe limitations, experiences symptoms even while at rest.  
 Mostly bedbound patients. (nYHA iV)
2.  there were frequent hospital admissions (>3 per year)
3.  the patient has frequent exacerbations of severe heart failure (>3 per year)
4.  the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%)
5.  the patient’s weight increases and fails to respond to increased dose of diuretics 
6.  General deterioration of the clinical situation (oedema, orthopnoea, nycturia,  
 dyspnoea) 
7.  the patient mentions ‘end of life approaching’ 
Chronic  
obstructive  
pulmonary  
disease
1.  the patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
2. the patient has substantial weight loss (±10% loss of bodyweight in six months)
3.  the presence of congestive heart failure 
4.  the patient has orthopnoea 
5.  the patient mentions ‘end of life approaching’ 
6.  there are objective signs of serious dyspnoea (decreased dyspnoea d’effort,  
 dyspnoea with speaking, use of respiratory assistant muscles and orthopnoea)
Cancer 1. Patient has a primary tumour with a poor prognosis 
2. Patient is moderately disabled; dependent. requires considerable assistance  
 and frequent care (Karnofsky score ≤50%) 
3.  there is a progressive decline in physical functioning
4.  the patient is progressively bedridden
5.  the patient has a diminished food intake 
6.  the presence of progressive weight loss
7.  the presence of the anorexia-cachexia syndrome (lack of appetite, general  
 weakness, emaciating, muscular atrophy) 
8. the patient has a diminished ‘drive to live’
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appendix 2 - reminder for proactive planning and disease specific potential problems 
(Proactive Palliative care Planning card, PPcPc) - Problems square
somatic domain social en financial domain 
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems : 
expected problems: 
scenario of dying: 
expected problems: 
Care provision and activity of daily living existential and psychological domain
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems:
expected problems: expected problems:
possible future problems 
Pain       dyspnoea       ileus       delirium     Fear      depression      coma     liver/renal failure  
strain of informal caregiver                          special technical care 
disease specific interest 
cHF : anaemia     deactivation defibrillator     weight 
coPd: medical /non-medical possibilities against dyspnoea 
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7Discussion
In this chapter the main findings of our studies are discussed and also put into a broader 
perspective. Strengths and weaknesses are discussed and recommendations for clinical 
practice, education and training and research are given. Finally, I end with a more general 
societal discussion on the topic of my thesis “Early proactive palliative care in general 
practice: identification, communication and structured planning”. 
In order to improve palliative care for patients with incurable, life limiting diseases, the 
World Health Organisation (WHO) stated already in 2002 that palliative care should be 
initiated in an early phase of the disease.1 An early start facilitates anticipatory palliative 
care in order to meet patients’ wishes and needs, to relieve symptoms and to prevent future 
symptoms and problems.2-4 Regardless this WHO recommendation, palliative care is often 
limited to a reactive approach, to relieve physical symptoms in the terminal phase and to 
patients with cancer. The GP, being the most appropriate professional to coordinate pallia-
tive care for home-dwelling patients, have expressed a need for guidance on how to recognise 
patients in need of palliative care and on how to structure anticipatory palliative care.5,6
Therefore, we developed an intervention which consists of a training for GPs in using the 
RADPAC7 as an aid to identify those patients that might profit of proactive palliative care, and 
in planning and providing proactive palliative care. By means of a cluster randomised con-
trolled trial we studied the effect of this intervention on the following outcome measures: 
number of out-of-hours-contacts, number of contacts with the patients’ own GP, number 
of hospitalisations and place of death. 
Fifty-nine GPs were included in the intervention group and received the intervention while 
the control group of 79 GPs did not receive the intervention and were asked to provide care 
as usual. The intervention8 consisted of three separate parts: 
1.  a five hour group training in early identification of patients who can be considered as 
being palliative patients, by means of the RADPAC, and in proactive palliative care 
planning; 
2.  an individual telephone coaching session per identified palliative patient with a physician 
specialised in palliative care to discuss the proactive care plan, and 
3.  two peer group sessions with the GPs with a focus on patient-GP communication re-
garding the intention of a palliative care trajectory.
In the RCT we did not find any differences in outcome between intervention and control 
group, in the number of contacts patients had with the out-of-hours GP cooperative, the 
number of contacts with the patients’ own GP, the number of hospital admissions, nor 
differences in place of death. 
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However, in the intervention group only 24% of the patients that died during the study 
period had been identified as in need of palliative care. And the patients that had been iden-
tified were identified by only half of the GPs in the intervention group. We performed a post-
hoc analysis in which we studied the same outcomes regarding those patients that had 
actually been identified by the intervention group GPs in comparison to all other patients 
from intervention and control group. This post-hoc analysis showed that identified patients 
had more contacts with their own GP and less hospitalisations in the last months before 
death, they more often died at home (not statistically significant) and less often in hospital.9 
Despite the negative outcome of the RCT, this post-hoc analysis seems to indicate that the 
intervention has the potential to improve different aspects of the quality of palliative care 
in primary care. 
Given this potential positive effect, what might be reasons that GPs aren’t capable to routinely 
practice proactive palliative care? 
This intriguing question is by no means easy to answer, but in our study we gain some 
insights which can be useful in further developing the complex concept of proactive pallia-
tive care. 
First of all, the concept of early identification. Although we strived for ‘early’ identification 
of palliative care needs, the indicators of the RADPAC we developed seemed to be related to 
quite advanced or final stages of the three studied diseases: cancer, COPD and CHF. A possible 
explanation for this mismatch between aim of the RADPAC indicators and result might be 
that at the start of our study, the concept of ‘early identification’ was not at all widely inte-
grated in the Netherlands.10-12 As an example, many of the experienced participants of the 
focus group interviews, one of the methods we used in the development of the RADPAC, 
struggled with the interpretation of terms and concepts like ‘terminal care’, ‘end-of-life 
care’, ‘advance care planning’ and ‘palliative care’.
Secondly, the RADPAC only contains somatic indicators, except for one, and therefore lacks 
connection to one of the pillars of general practice: the context of the patient.13,14 In an inter-
view study Claessen et al. found that GPs identify palliative patients via hospital discharge 
letters and specific signals like increased care dependency from others, not completely re-
covering of an intercurrent disease, signals from family caregivers, home care providers or 
medical specialists.15 Considering this, we might conclude that triggers that helping to iden-
tify palliative patients don’t need to be disease-specific. Such ‘natural highlighting moments’ 
might be easier to apply as identification aids, as they are closer to daily practice. In the past 
few years, parallel to my research, in several other European countries palliative care needs 
identification tools for general practice have been developed. Maas et al. compared seven 
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of such tools.16 At the moment of this review, none of them were validated. Six tools were 
developed specifically for primary care, although SPICT (also in Dutch)17 and NECPAL-
CCOMS-ICO can also be applied in hospital settings. Most tools start with the surprise 
question: ‘Would I be surprised if this patient died in the next year?’ which appeared to be 
useful for GPs in identifying palliative patients with cancer18, but not for patients with COPD, 
CHF19 or frail elderly.20 Only the SPICT, an identification tool from Scotland, starts with a kind 
of ‘natural’, generic indicators for deteriorating health.21 Another reason why such a generic 
method might fit better in general practice, is that a large part of this patient population 
has multimorbidity, which hampers application of a disease-specific tool. General indicators 
specifically for primary care might be ‘diagnosis of an incurable, life-limiting disease’, or 
hospital discharge after such a diagnosis, but also the combination with non-disease specific 
complicating factors in the patient or family history in the physical, social, emotional or 
existential domains. Examples might be being single, suffering from anxiety or depression, 
or having a family caregiver with a cognitive impairment or who is overburdened.22 
Thirdly, an identification tool is not enough to facilitate GPs to timely identify the palliative 
care needs of their patients. In addition, other steps must be taken to raise awareness among 
other health care professionals about the fact that patients with a potentially life-threatening 
illness can benefit from an early start of palliative care alongside disease modifying treatment 
(curative treatment or life prolonging therapy),2,23,24 as defined in the definition of palliative 
care by the WHO.1 
As long as medical specialists continue to follow up their patients who actually are in a pal-
liative phase but are not yet identified as such and with whom the advantages of proactive 
palliative care have not been discussed, it is very difficult for GPs to take this role. Particularly 
for other medical specialists than medical oncologists, (e.g. cardiologists, pulmonologists) 
considering any of their patients for a palliative care program is no common practice.25,26 
Similar to GPs, medical specialists should also timely identify and discuss proactive palliative 
care, as patients often already have a long-lasting (disease orientated) relationship with them 
and therefore trust them. However, like GPs, also medical specialists struggle to define the 
moment to start palliative care.27 In our research group, identification of patients with COPD 
by medical specialists is currently being studied in a prospective, controlled study.28 Up to 
now, disease-specific clinical practice guidelines hardly provide clear recommendations on 
how to early identify palliative care patients and on proactive care planning.29-31 
Sharing a Key Information Summary (KIS) is another practical application, although not yet 
widespread. A recent study of Tapsfield et al. showed that using KIS, a shared electronically 
and updated real time system in which GPs and other care providers can routinely share the 
anticipatory care plans, 60% of the patients were identified32. Within this group of identified 
patients, the percentage of patients with cancer was the highest (75% identified) and that 
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of patients with chronic organ failure the lowest (41% identified). Particularly in the latter 
group, the medical specialist continues to be the main professional caregiver, which implies 
that often the GP is not aware of the condition of the patient or not in a position to provide 
palliative care until the final phase, which is a missed chance for all stakeholders.27,33,34 
Shared care between primary and secondary care appeared to be successful in the treat-
ment of chronic diseases;35,36 we are currently pilot-testing shared palliative care in several 
initiatives in our region, but also in other parts of the Netherlands. 
Lastly, even when they had identified the patient, the GPs experienced barriers to start 
discussing proactive palliative care with the patient and his family. In our study, GPs re-
ported to be reluctant, fearing to take away all hope of their patients, and to experience 
difficulties with choosing the right moment to start discussions about the future. This is in 
agreement with several other studies.37-39 Besides, Weeks et al. showed that patients are 
more satisfied with the communication of doctors who give unrealistic positive informa-
tion about the effects of chemotherapy than of those who give realistic information.40
However, Green showed that discussions about the end of life don’t have to take away 
hope.41 Additionally, patients want their GP to talk openly and honestly about relevant end-
of-life issues.42,43 What also needs to be taken into account is that GPs who experienced 
barriers in discussing the future had already identified the respective patients as being 
palliative; all patients that were not identified at all lacked such discussions anyhow. 
Several training methods can help GPs and medical specialists to initiate such conversa-
tions about future care and the end of life.44,45 A recent review on communicating future 
illness progression and end of life provides some guidance.46 The authors concluded that 
there are different ways to initiate talking about feelings and plans in relation to end of life. 
Posing a hypothetical question strongly encourages on-topic talk, while indirect references 
to the difficult issues form a more gentle way of ‘pushing at the door’ of the topics, which 
some patients take up and some deflect. Despite the WHO definition of palliative care and 
the intention of professionals, the general public still mainly associates palliative care with 
the terminal phase and dying.39 Therefore more effort is needed to raise public awareness 
of the concept of palliative care. Or, as an alternative solution, a new term should be con-
sidered that better describes the intention of proactive palliative care, namely ‘anticipatory 
care’ or ‘supportive care’.47 These terms refer to the supportive character, to the treatment 
goals aiming to relieve symptoms and to increase quality of life, to information exchange 
between professionals, but without the direct association with a terminal phase or dying. 
This is also in line with the fact that anticipatory care, in contrast to advance care planning, 
aims to anticipate on all future care needs, not just regarding the end of life. By not directly 
relating this kind of care to the end of life, hope is not immediately shatterd, and the trustful 
patient-doctor relationship not threatened, which to my experience will facilitate good 
care provision. 
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Our study (chapter 5) showed that GPs in the intervention group more often provided multi-
dimensional care, with particularly more attention for the spiritual and psychosocial domains 
than GPs in the control group. This is an important finding, as Evans et al. showed in their 
study that the spiritual and social domain did not get enough attention in their study.48 This 
result is likely related to the training we used and to practicing with the Proactive Palliative 
Care Planning Card (PPCPC) that structures GPs discussion with the patients and their 
informal caregivers, and help to explore patients actual and potential problems and needs 
on the different palliative care domains (Figure 1). The name of the PPCPC changed during the 
research into a less difficult name, Problems Square. This Problem Square, in combination 
with the training with simulation patients, will have contributed to this positive finding.
strengths and weaknesses
This is the first thesis that systematically studied the effect of training GPs in identifying 
patients in need of palliative care and in providing proactive palliative care and that evalu-
ated long-term effects of this training. Another strength is the large number of GPs that 
was included in a short period of time. This shows their large interest in palliative care and 
a strong need for education and skills training. However, only 57% of the included GPs com-
pleted the questionnaire with data of deceased patients, one year after start of the interven-
tion. Therefore we missed the data of the deceased patients of the non-responding GPs. The 
response rate of the survey in chapter 5 was even lower. Probably, only the very motivated 
GPs have responded. For those reasons, the results should be interpreted with caution.
When we started our study, the Prognostic Indicator Guide (PIG) as part of the Gold Standards 
Framework (GSF) already existed.49 In fact, our study was inspired by the GSF. However, at 
that time the indicators of the GSF were not evidenced-based. In 2008, Qaseem et al. did 
not identify any evidence-based validated identification tools that were able to mark the 
optimal timing to initiate palliative care50, even though all kind of studies looked at predic-
tion of mortality, at survival and prognostication. We aimed to develop an evidence- and 
practice-based tool. We succeeded in reaching that aim, although validation was restricted 
to face-validation (expert opinion). 
However, the study also has several weaknesses. In chapter 4 we used place of death as one 
of the outcome measures, as dying at the preferred place, which mostly is at home, is con-
sidered a quality indicator for palliative care.51 However, dying at home is not always the 
best place, for example when a patient has no family or friends to take care of him. Besides, 
the preferred place of death can change over time.52 De Roo et al. found a strong correlation 
between death at home and preferred location of death,53 which affirms that location of death 
might have been, within the study design, a good and realistic outcome variable. Ideally, 
quality of life would have been the primary outcome. But, as the GPs in the control group 
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did not have the RADPAC for palliative patient identification, we would not have been able 
to collect comparable data in the control group. In a currently ongoing study on proactive 
palliative care in patients with COPD, patients are included during a hospitalisation for an 
acute exacerbation, which allowed for prospective collection of patient data in the control 
group as well as the intervention group.28
The positive findings described in chapter 4 were restricted to the post-hoc analysis, which 
was not described in the study protocol.8 Identified patients had more contacts with their 
own GP, less hospitalisations, more often died at home (67%) (although not statistically sig-
nificantly) and less often died in hospital (14%). We don’t know whether these positive findings 
are related to the intervention, or caused by the fact that this identified group of patients 
differs from the other patients (age 64.8–74.6, male 61%-54%, cancer 86%-66%). It is known 
that various factors influence death at home.54-56 In a recent Dutch study concerning place 
of death of home-dwelling patients that died after a protracted terminal illness, 52.5% of 
figure 1  - reminder for proactive planning and disease specific potential problems  
(Proactive Palliative care Planning card, PPcPc) - Problems square
somatic domain social en financial domain 
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems : 
expected problems: 
scenario of dying: 
expected problems: 
Care provision and activity of daily living existential and psychological domain 
                                                     Action plan                                                      Action plan 
Actual problems: Actual problems:
expected problems: expected problems:
possible future problems 
Pain       dyspnoea       ileus       delirium     Fear      depression      coma     liver/renal failure  
strain of informal caregiver                          special technical care 
disease specific interest 
cHF : anaemia     deactivation defibrillator     weight 
coPd: medical /non-medical possibilities against dyspnoea 
167discussion
the patients died at home.53 In a study that only concerned patients with cancer 29.4% died 
in hospital,57 and a study concerning Dutch patients with diseases being indicative of pal-
liative care needs, 25% died in hospital.58 We consider the significant lower percentage of 
hospital deaths (14% versus 32%) as a more relevant outcome measure than an increase of 
home death, as dying in hospital is often related to a crisis and thus undesirable. Besides, 
dying in a hospice or in a nursing home can also be a preferred place and a chosen alternative 
of dying at home.
Regarding the outcome measure ‘hospitalisations in the final 3 months of life’ we were not 
able to make a distinction between unplanned and planned hospitalisations, as an inter-
vention within proactive palliative care, for example for palliative radiation therapy or for 
inserting a double J catheter in an obstructed ureter. In order to use this outcome measure in 
the future, the reason for hospitalisation and if the hospitalisation is planned or unplanned 
needs to be assessed.
reCoMMendations 
Recommendation for general practice
In general, GPs in the Netherlands perform well in comparison with other developed coun-
tries concerning the low percentage of patients with cancer that die in hospital,57 as well as 
concerning discussing end-of-life aspects.48 However, the delivery of palliative care according 
to the WHO definition is not optimal yet. GPs should also become aware of patients with 
non-malignant diseases that might benefit from proactive palliative care. Therefore, we 
recommend GPs to identify palliative patients with the SPICT-NL,17 and to involve their 
practice assistants and nurse practitioners in this identification process. It is not always the 
GP herself who sees the patient or his family, who sees the discharge information, or who 
has contact with home care, but this can also be another professional within the primary 
care practice. Besides, the contact of the GPs practice assistant or the nurse practitioner with 
the patient or family differs from the contact the GP has: they might see relevant aspects 
that can help the GP to identify palliative care needs. Hence demonstrating the advantages 
of a primary care team approach. 
For proactive palliative care planning, we recommend using the Problems Square to make 
a structured, multidimensional actual and future problems and needs inventory. GPs are, 
more than any other health care professional, familiar with ‘consultation’; also in palliative 
care this can contribute to high quality palliative care provision. In the Netherland, 24/7 
free of charge palliative care consultation managed by professionals trained in palliative care 
is available for GPs, as a service of the Netherlands Comprehensive Cancer Centre (IKNL). 
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I recommend GPs to use this consultation opportunity also proactively for discussing the 
different future scenarios.
To learn from each other within the primary care team, we recommend evaluating each 
deceased patient with all stakeholders. In this way, the care for not only the patients that 
actually did receive proactive palliative care, but also for those who unintentionally did not 
is considered.59 
 
Recommendations for education
Upon graduation, every medical doctor is required to pledge a medical oath, based on Hippo-
crates. It states that a physician takes care of the ill, promotes health, relieves suffering and 
does no harm. Most medical students start their education with the idea that a doctor cures 
people. It would be an enrichment if their educational program would give more attention 
to the last part of the oath, relieving suffering in patients with chronic, incurable diseases 
that might benefit from proactive palliative care.60 By implementing this topic early in the 
educational programme of medical students, young doctors will realise from the beginning 
that not being able to cure a person does not imply that the doctor fails, and that there are 
all kind of options for delivering good care to, and even for increasing the resilience of, 
chronically ill persons. Also specific training in communication about the future perspec-
tives of a patient and his proxies needs more attention. In our university medical hospital, 
a new medical curriculum started in 2015, in which more attention than before is given to 
palliative care, pain management and communication training, which is an excellent step 
in the right direction.61 Besides, a research project has started recently, financed by the 
Netherlands Organisation for Health Research and Development (ZonMw) within the Dutch 
national programme for palliative care ‘Palliantie’. In this project all university medical 
expertise centres for palliative care are involved and together they aim to realise more 
attention for palliative care for all medical students by developing specific educational tool 
kits. We hope that early identification of palliative patients and proactive palliative care 
planning will be part of this, as each medical professional should have basic knowledge 
about palliative care and should know where to refer to for complex palliative care.
Recommendations for research
Despite our efforts and those of others, early identification of palliative patients still remains 
problematic. Therefore, we recommend that individual research groups from all over the 
world studying early identification of palliative patients start a global collaboration group in 
order to develop, validate and implement one international tool. The EAPC primary pallia-
tive care steering group, led by professor dr. Scott Murray, would be a good choice to foster 
such a group, as the developers of several identification tools are members of this group. 
Initiatives to identify frail elderly and to improve their care certainly have similarities with 
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the aspects of palliative care described in this thesis. I therefore suggest cooperation between 
researchers in this field.62 We also recommend to further explore barriers experienced by 
both GPs and patients in discussing palliative care issues together by qualitative research, 
for example with a narrative approach.63,64 Next, continuity of care between primary and 
secondary care settings regarding proactive palliative care is an important research topic. 
I recommend to study barriers, facilitators and cost-effectiveness of integrated care path-
ways involving optimal palliative care parallel to disease-orientated care. 
general soCietal disCussion
The intervention we developed was meant for GPs. However, I have the opinion that infor-
mation about palliative care still needs to be widely spread in the society. Today, health care 
and health care insurance companies almost completely focus on the curative intention of 
treatments; as if life would be malleable as well as death.65 The media focuses equally on 
this in for example a documentary about a patient with severe heart failure who receives 
an artificial heart while waiting on a heart transplantation. Or the website of the Dutch 
Royal Cancer foundation (KWF) that states: ‘giving up is no option’ and that states that all 
cancer can be cured within a few decades.66
In my opinion, societal discussion regarding the final phase of life should concern quality 
of life and quality of dying. Care that is congruent with the wishes, the life, the context of the 
patient and his family: palliative care. Thankfully, small steps in this direction have been 
made recently. In March 2015 a report was launched titled ‘not everything that is possible 
needs to be done’ in which society, patients, their family and physicians are informed and 
strengthened in making their own choices timely, in making choices that are not always 
primarily or solely driven by choices for life prolongation.67 
On the governmental website Kiesbeter.nl, meant as a monitor with information about 
quality of care provision in individual settings all over the Netherlands,68 palliative care 
and discussing patient’s own wishes with the GP is often mentioned as a move in the right 
direction. Generally, patients seem only marginally informed about the spectrum of pallia-
tive care. Society and most patients only consider euthanasia as an end-of-life topic to discuss 
with their GP by statements as: ‘Doctor, if my life is not more than that of a hothouse plant, 
I want to have an injection’, and hardly or not at all about palliative care options. This stresses 
the need for good information and patient education on early identification, and proactive 
palliative care. All health care professionals, as well as the government, health care insurance 
companies and media have an important role in enhancing this knowledge. 
Until now, euthanasia receives a lot of attention in the national and international media, 
which gives the wrong impression that this is the only and preferred way of dying in the 
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Netherlands. In fact, 97% of the Dutch citizens die without euthanasia.69 Patients, at all ages 
and all kind of stages of their lives, should be informed better about, and stimulated to 
consider and discuss the different aspects and choices regarding end-of-life decisions and 
possibilities including good palliative care. The palliative care expertise centres of the 
Dutch academic hospitals, the IKNL (Integraal Kankercentrum Nederland; Netherlands 
Comprehensive Cancer Centre), Palliactief (Dutch multiprofessional association for profes-
sionals in palliative care), Agora (Dutch organisation that serves as a platform for the exchange 
of information on end-of-life issues) and patient organisations all have an important role 
in educating the general public on what palliative care intends and can do for patients and 
their proxies. This all together will facilitate patients, their family, GPs and medical specialists 
to discuss the possibilities of proactive palliative care.
Quality indicators used in general practice and in hospitals mostly measure aspects of care 
that are related to diagnosis, curation or disease improvement.70,71 For example, regarding 
the care for patients with COPD such indicators are the percentage of conversations about 
smoking cessation, the percentage of patients receiving spirometry in the last month, or the 
percentage of patients for whom functioning in the past 12 months has been documented 
in a structured way. Up to now, no obligatory quality indicators exist that measure 1) if a 
conversation about end of life has taken place, 2) if shared decision making was used about 
quality of life related decisions and 3) if it has been discussed and documented whether an 
incurable patient still wants to be hospitalised. If such quality indicators would be imple-
mented, health care professionals would emphasize that accepting the boundaries of mal-
leability of life can result in good care. 
Recently, the State Secretary for Health, Welfare and Sports, Van Rijn, stated that financing 
and rules on indications for receiving specific care or to be refered to a specific setting (like 
a hospice) should and may not hinder the choice for the location of death, as all health care 
insurers have the obligation to provide adequate end-of-life care.72 Health care insurers 
make a distinction between palliative care and palliative terminal care, and Health Insurers 
Netherlands (Zorgverzekeraars Nederland) state that everyone who needs it will receive 
palliative terminal care.73 However, until now, no specific financial reimbursement exists 
for proactive palliative care, although it has been shown that patient-centred palliative care 
at home for patients with CHF is cost-effective.74 Therefore I advocate remuneration of pro-
active palliative care by the GP: by providing this, less patients will die in a hospital which 
might be cost-effective. As palliative care currently is on the agenda of the government 
and politicians, the time seems ripe to study cost-effectiveness of proactive palliative care. 
Since 2015, health care is strongly reorganised in the Netherlands with a transfer of the 
responsibility for organising long term health care support from the central government 
towards the insurance companies and municipalities.75 At the same time, the coordinating 
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role of family caregivers and volunteers has become more important as a result of a decrease 
in central governmental support of professional care. Besides, municipalities became respon-
sible to organise, support and arrange cleaning personnel at home as well as for specific 
support for family caregivers when they are not able to provide care themselves. The district 
nurse provides professional nursing care at home, like dispensing medication or assisting 
the patient in taking a shower. Together with the municipality the nurse decides what kind 
of care and support is needed. This seems logical, but when it concerns proactive palliative 
care it is not only a manner of checking what is necessary at that moment, but also to antici-
pate on future care needs. Realising this will need a paradigm shift in home care organisa-
tions, in municipalities as well as in health care insurers and in the government. And last 
but not least, this needs a higher level of awareness among the general population too.
general ConClusion 
This dissertation provides insights in the effects of and barriers to early identification of 
palliative patients and proactive palliative care planning by GPs. Training GPs in early iden-
tification of palliative patients and proactive palliative care planning looks promising. And 
when barriers that hamper patient identification or GP/patient communication about future 
care are overcome, such proactive care planning will certainly contribute to the improve-
ment of the quality of palliative care in the Netherlands. 
Finally, the story of Mr Roos, receiving ideal proactive palliative care.
Mr Roos 80 years old, known for years with congestive heart failure. About ten years ago, 
when his cardioverter defibrillator (ICD) was implanted, the cardiologist in whom he and his 
wife have great confidence, discussed the progressive illness with Mr. Roos, and that some-
where in the future this ICD needed to be deactivated. Although his condition slowly declined, 
he had a good life, with regular consultations with his cardiologist, the heart failure nurse, and 
his GP. 
Recently, he had an acute exacerbation of his heart failure, and he felt that he lost the resilience 
to completely recover. Again, the cardiologist told him that he is not able to help him recover to 
his previous condition, but that he, together with the GP, will provide optimal comfort care to 
him: palliative care. He also suggests to him and his wife to make an appointment with their 
GP, and tells them that he will inform the GP by phone and by mail about his condition. 
In the next months, Mr and Ms Roos regularly have an appointment with their GP to talk about 
all kind of things: about his son who builds a green house, about his progressive dyspnoea, 
about his fear for choking and leaving his wife behind, about her fears and mood, and their 
wishes about the end of his life. They also talk about home care to assist him with his activities 
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of daily living and to monitor Mr and Ms Roos. Once in a while the practice assistant phones 
Ms Roos, and asks her how she is coping. 
The Gp as well as the cardiologist empower the family. Mr Roos regularly visits the hospital day 
care. The interval between these visits becomes shorter and shorter, but Mr Roos still finds his 
life worth living. After a period in which he went to hospital day care weekly for management 
of fluid overload, in a shared decision making process of the GP, the cardiologist, Mr Roos and 
his wife, it is decided to inactivate the ICD, and to extend home care. The next day Mr Roos 
becomes tired, dead tired, and very short of breath. Medication does not provide relief any-
more. He says farewell to his wife, his children and his life. 
To relief his intractable symptoms, he is sedated and dies at home amidst his wife and children. 
The GP informs the cardiologist of the death of Mr Roos and they evaluate his trajectory. In the 
next multidisciplinary primary care team meeting the GP, the practice assistants and home 
care also evaluate the trajectory of Mr and Ms Roos. 
In the weeks after Mr Roos died, the GP sees Ms Roos twice. Around All Souls’ Day, Ms Roos 
receives a hand-written postcard from the GP and practice assistants to give her and her late 
husband a moment’s thought. 
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In chapter 1, the rationale for this thesis on early identification of and anticipatory pallia-
tive care planning for patients in general  practice  is explained. In 2002 the World Health 
Organisation (WHO) already stated that palliative care should be available for all persons 
who suffer from cancer or other life-limiting chronic diseases, in an early stage of the 
disease, alongside the usual disease-modifying care. However, when this research project 
was started in 2008, palliative care was still mainly limited to terminal, reactive care for 
patients with cancer.
In this chapter, we explain why we have focused on training general practitioners (GP) in 
early identification and proactive care planning. Being the gatekeeper of care, and often 
working from a long lasting relationship with the patient and his family, the general prac-
titioner seems to be the most appropriate professional to coordinate the care for patients 
with advanced stage of cancer, chronic obstructive pulmonary disease (COPD) or conges-
tive heart failure (CHF), especially considering that most of these patients live at home 
and home is their desired place for dying.
 
In chapter 2 the development of a tool to help GPs identify patients with cancer, COPD or 
CHF that might profit of palliative care, is reported. No validated tools predicting the optimal 
timing for initiating palliative care had been determined previously. We used a three-step 
procedure, including a literature review, focus group interviews with input from the multi-
disciplinary field of palliative healthcare professionals, and a modified Rand Delphi process 
with GPs. The three-step procedure was used to develop sets of indicators for the early iden-
tification of CHF, COPD, and cancer patients who could benefit from proactive palliative care.
This resulted in the RADboud indicators for Palliative Care needs (RADPAC), three compre-
hensive sets of indicators to support GPs in identifying patients with CHF, COPD, and cancer 
in need of palliative care. For CHF, seven indicators were found: for example, more than 3 
hospital admissions. For COPD, six indicators were found: such as, Karnofsky score ≤50%. 
For cancer, eight indicators were found: for example, worse prognosis of the primary tumour.
We concluded that RADPAC was the first tool developed from a combination of scientific 
evidence and practice experience that can help GPs in the identification of patients with 
CHF, COPD, or cancer, who are in need of palliative care. Applying the RADPAC facilitates 
the start of proactive palliative care and aims to improve the quality of palliative care in 
general practice.
 
In chapter 3 the study protocol of the randomised controlled trial is provided and explained. 
An early identification of patients who can benefit from palliative care to enable proactive 
182 suMMerY
palliative care might increase the quality of their remaining life. However, at the moment 
we started this study, this was no common practice and had hardly been addressed in scien-
tific literature. Still, palliative care was mainly limited to the terminal phase and restricted 
to patients with cancer. Therefore, we wanted to train GPs in identifying palliative patients 
in an earlier phase of their disease trajectory and in delivering structured proactive palliative 
care. The aim of our RCT was to determine if this training could improve different aspects 
of the quality of the remaining life of patients with severe chronic diseases such as COPD, 
CHF and cancer. A two-armed randomised controlled trial design was chosen. The following 
outcome variables were studied: place of death, the number of hospital admissions and the 
number of GP out of hours contacts. We expected that this study would increase the number 
of identified palliative care patients and improve different aspects of quality of palliative 
care. This is of importance to improve palliative care for patients with COPD, CHF and cancer 
and their informal caregivers, and to empower the GP. In this chapter the study protocol is 
described and possible strengths and weaknesses and consequences have been outlined.
 
In chapter 4, the results of the RCT as mentioned in chapter 2, are described. Most patients 
with advanced cancer, debilitating COPD or CHF live at home. In existing literature GPs 
asked for guidance in how to recognise patients in need of palliative care in a timely way 
and to structure anticipatory care. For that reason, we developed a training for GPs in iden-
tifying patients in need of palliative care and in structuring anticipatory palliative care 
planning and studied its effect on out-of-hours contacts, contacts with their own GP, hos-
pitalisations and place of death.
We performed an RCT in which GPs in the intervention group were trained in identifying 
patients in need of palliative care and anticipatory palliative care planning. Next, for each 
identified patient, they were offered a coaching session with a specialist in palliative care to 
fine-tune a structured care plan. The GPs in the control group did not receive training or 
coaching, and were asked to provide care as usual. After one year, characteristics of patients 
who died of cancer, COPD or CHF in both study groups were compared with mixed effects 
models for out-of-hours contacts (primary outcome), contacts with their own GP, place of 
death and hospitalisations in the last months of their life (secondary outcomes). As a post-
hoc analysis, of the identified patients (of the intervention GPs) these figures were compared 
to all other deceased patients, who had not been identified as in need of palliative care.
We did not find any differences between the intervention and control group. Yet, only half 
of the trained GPs (n=28) identified patients (n=52), which was only 24% of the deceased 
patients. Those identified patients had significantly more contacts with their own GP 
(B 4.5218; p 0.0006), were less often hospitalised (OR 0.485; p 0.0437) more often died at 
home (OR 2.126; p 0.0572) and less often died in the hospital (OR 0.380; p 0.0449). We 
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recommend future controlled studies that try to further increase identification of patients 
eligible for anticipatory palliative care.
 
In chapter 5 we studied whether GPs, one year after being trained for the intervention 
condition of the RCT, identified more palliative patients and provided more often multi-
dimensional and multidisciplinary palliative care compared to untrained GPs.
We performed a survey one year after the GPs in the intervention condition of the RCT 
received their training. With a questionnaire, all 134 participating GPs were asked how 
many palliative patients they had identified, and whether anticipatory palliative care was 
provided. We studied the number of identified palliative patients, expected lifetime, contact 
frequency, whether multidimensional care was provided and which other disciplines were 
involved. We found that trained GPs identified more palliative patients than untrained GPs 
(median 3 versus 2; p 0.046) and that they provided multidimensional palliative care more 
often (p 0.024). In both conditions, most identified patients had a diagnosis of cancer.
We conclude that RADPAC sensitises GPs in the identification of palliative patients. Trained 
GPs provided multidimensional palliative care more often. Further adaptation and evaluation 
of the tools and training is necessary to improve early palliative care for patients with organ 
failure.
 
In chapter 6, we described how GPs and consultants evaluated the different aspects of the 
training that the GPs in the intervention condition of the RCT followed, and its impact on 
their daily practice. GPs were trained to timely identify palliative patients with cancer, COPD 
or heart failure with the help of the RADboud indicators for PAlliative Care needs (RADPAC) 
and to make a proactive, structured care plan. They were offered two additional training 
sessions, in which they practiced with simulation patients, and for every individual patient, 
a consultation took place with a palliative care consultant to fine-tune the care plan. Two years 
after the training semi-structured interviews with the GPs were organised. Additionally, a 
focus group interview with the consultants took place after which the data were analysed 
with a thematic content analysis.
Six consultants and nine GPs participated. The majority of GPs mentioned positive changes 
in their thinking or acting regarding early palliative care. Part of them still used the tool to 
identify patients; most of the others reported that they had internalised the indicators. 
Although half of them still experienced discussing end-of-life aspects as difficult, particu-
larly in patients with organ failure, others reported that they discussed the future with their 
palliative patients more easily.
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Most GPs and consultants were positive about the training and applying it in daily practice. 
Nevertheless, we conclude that the timely identification of palliative patients with COPD or 
CHF, and the issue of discussing possible scenarios with patients, should have more atten-
tion in future training.
 
In chapter 7, the final chapter of this thesis, the main findings and strengths and weaknesses 
of the studies are discussed and placed in a wider perspective. This chapter ends with a 
more general societal discussion on the topic of this thesis “Early proactive palliative care 
in general practice: identification, communication, and structured planning”.
Despite the negative outcome of the RCT, the post-hoc analysis indicates that the interven-
tion has the potential to improve different aspects of the quality of palliative care in primary 
care. We discussed four possible reasons that might explain why GPs do not routinely practice 
proactive palliative care: 1. the concept of early identification; 2. the RAPDAC lack of connec-
tion to one of the pillars of general practice: the context of the patient; 3. the lack of aware-
ness of the benefits of an early start of palliative care alongside disease modifying treatment 
among other health care professionals; 4. experienced barriers in discussing proactive pal-
liative care with the patient and his family.
The main message of the general societal discussion is the importance of raising awareness 
all over society of what palliative care actually is. 
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saMenvatting
In hoofdstuk 1 wordt de reden voor dit proefschrift ‘Tijdige proactieve palliatieve zorg in de 
huisartspraktijk’ (early proactive palliative care in general practice)  beschreven. Al in 2002 
stelde de Wereld gezondheidsorganisatie (WHO) dat palliatieve zorg in een vroege fase van 
ziekte beschikbaar moet zijn, naast de normale op ziekte gerichte zorg, voor alle patiënten 
die lijden aan kanker en andere levensbedreigende chronische ziekten.
In 2008, toen dit onderzoeksproject startte, bestond palliatieve zorg vooral uit terminale, 
reactieve zorg voor patiënten met kanker. In dit hoofdstuk wordt uitgelegd, waarom we 
sterk onze aandacht richten op het trainen van huisartsen in het vroeg identificeren van 
palliatieve patiënten en proactieve palliatieve zorgplanning. De huisarts fungeert als poort-
wachter en heeft meestal een langdurige relatie met de patiënt en zijn naasten. De huisarts 
lijkt de meest aangewezen professional om palliatieve zorg te coördineren voor patiënten 
met een gevorderd stadium van kanker, chronisch obstructieve longziekten (COPD) en hart-
falen (CHF). Het gaat hierbij meestal om patiënten die thuis wonen en daar ook willen sterven. 
In hoofdstuk 2 wordt de ontwikkeling beschreven van een instrument voor huisartsen met 
als doel patiënten met kanker, COPD en CHF tijdig te identificeren, die baat kunnen hebben 
bij proactieve palliatieve zorg. Op het moment van starten van dit onderzoek in 2008 was 
er geen gevalideerd instrument voor het optimale moment van starten van palliatieve 
zorg. Voor de ontwikkeling van dit instrument gebruikten we een 3-stappen plan. Stap 1 
was een literatuur review. Stap 2 behelsde meerdere focusgroep-interviews met input van 
professionals uit het multidisciplinaire palliatieve zorgveld. Stap 2 werd gevolgd door de 
laatste stap, een Rand Delphi procedure met huisartsen. Dit 3-stappen plan heeft geresul-
teerd in de RADboud indicators for Palliative Care needs (RADPAC), een instrument dat de 
huisarts kan ondersteunen in het vroeg identificeren van patiënten met kanker, COPD en 
CHF, die baat kunnen hebben bij proactieve palliatieve zorg. 
Voor CHF zijn er 7 indicatoren gevonden, zoals bijvoorbeeld: meer dan 3 ziekenhuisopnames 
per jaar. Voor COPD vonden we 6 indicatoren, zoals bijvoorbeeld: Karnofsky score ≤50%. 
Voor kanker vonden we 8 indicatoren, zoals bijvoorbeeld: slechte prognose bij een primaire 
tumor. 
De RADPAC is het eerste wetenschappelijk onderbouwde instrument voor een vroege iden-
tificatie van palliatieve patiënten, een instrument dat ontwikkeld is door middel van een 
combinatie van wetenschappelijk bewijs met ervaringen uit de praktijk. Het gebruik van de 
RADPAC vergemakkelijkt het starten van proactieve palliatieve zorg en beoogt de verbete-
ring van palliatieve zorg in de huisartspraktijk. 
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Hoofdstuk 3 beschrijft het protocol van de gerandomiseerd gecontroleerde trial (RCT). Het 
vroeg identificeren van patiënten die baat kunnen hebben bij proactieve palliatieve zorg, 
draagt mogelijk bij aan een betere kwaliteit van leven. Tot de start van het onderzoek was 
deze denkwijze geen gemeengoed en in de wetenschappelijke literatuur werd er nauwe-
lijks aandacht aan besteed. Palliatieve zorg werd veelal beperkt tot de terminale fase bij 
patiënten met kanker. Daarom wilden we huisartsen trainen in het vroeg identificeren van 
palliatieve patiënten en in het geven van proactieve palliatieve zorg. Het doel van de RCT was 
te bepalen of deze training verschillende aspecten van de kwaliteit van leven van patiënten 
met ernstige chronische ziekten, zoals kanker, COPD en CHF, kan verbeteren. We ontwierpen 
een twee-armige gerandomiseerde gecontroleerde trial. Als uitkomstmaten gebruikten we: 
plaats van overlijden, het aantal ziekenhuisopnames en het aantal avond-nacht-weekend 
(ANW) contacten met de huisarts. We verwachtten dat deze studie het aantal geïdentifi-
ceerde palliatieve patiënten zal vergroten en verschillende aspecten van de kwaliteit van 
palliatieve zorg zal verbeteren. Dit is van belang voor patiënten met COPD, CHF en kanker en 
hun naasten. Het versterkt bovendien de rol van de huisarts ten aanzien van palliatieve zorg.
Hoofdstuk 4 presenteert de resultaten van de in hoofdstuk 3 beschreven RCT. In de be-
staande literatuur vragen huisartsen handvatten voor het tijdig herkennen van patiënten 
die baat kunnen hebben bij palliatieve zorg en handvatten voor proactieve palliatieve zorg. 
Om die reden ontwikkelden wij een training in het tijdig identificeren van palliatieve patiën-
ten en in het structureren van proactieve palliatieve zorg en bestudeerden wij de invloed 
ervan op het aantal ANW-contacten, contacten met eigen huisarts, ziekenhuisopnames en 
plaats van overlijden. Huisartsen in de interventie groep werden getraind zowel in het tijdig 
identificeren van patiënten die baat konden hebben bij palliatieve zorg als in proactieve 
palliatieve zorg planning. Voor elke patiënt die zij identificeerden, werd hen een coaching 
sessie met een specialist in de palliatieve zorg aangeboden voor het preciezer uitwerken 
van het gestructureerd zorgplan. Huisartsen in de controlegroep kregen geen opleiding en 
coaching. Hen werd gevraagd om zorg te verlenen zoals gebruikelijk. Na één jaar werden 
kenmerken van patiënten die overleden waren aan kanker, COPD of CHF, in beide studie-
groepen vergeleken door middel van mixed effect models voor ANW-contacten (primaire 
uitkomst), contacten met eigen huisarts, plaats van overlijden en ziekenhuisopnames in de 
laatste maanden van hun leven (secundaire resultaten). In een post-hoc analyse werden de 
geïdentificeerde patiënten van de interventie huisartsen vergeleken met alle andere, niet 
geïdentificeerde overleden patiënten.
We vonden geen verschil tussen de interventie groep en de controle groep. Slechts de helft 
van alle getrainde huisartsen (28) identificeerde patiënten (52), wat slechts 24% was van alle 
overleden patiënten. Deze geïdentificeerde patiënten hadden significant meer contacten met 
hun eigen huisarts (B 4.5218; p 0.0006), werden minder vaak in het ziekenhuis opgenomen 
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(OR 0.485; p 0.0437), overleden vaker thuis (OR 2.126; p 0.0572) en stierven minder vaak in 
het ziekenhuis (OR 0.380; p 0.0449). Meer onderzoek is nodig om tijdige identificatie van 
palliatieve patiënten die baat kunnen hebben bij palliatieve proactieve zorg te vergroten. 
In hoofdstuk 5 worden de resultaten beschreven van een studie waarin we onderzochten 
of huisartsen, een jaar na de interventie training, meer palliatieve patiënten identificeerden 
en vaker multidimensionele en multidisciplinaire zorg leverden dan de ongetrainde huis-
artsen. 
Een jaar nadat de huisartsen in de interventie groep getraind waren, kregen alle 134 deel-
nemende huisartsen een vragenlijst. Daarin werd gevraagd hoeveel patiënten zij geïdentifi-
ceerd hadden en of er proactieve palliatieve zorg verleend was. We bestudeerden het aantal 
geïdentificeerde patiënten, de verwachte levensduur van de patiënten, de contactfrequentie, 
of de zorg multidimensioneel was en welke andere disciplines er betrokken waren. 
De getrainde huisartsen bleken meer palliatieve patiënten geïdentificeerd te hebben dan de 
niet getrainde huisartsen (mediaan 3 versus 2; p 0.046). Ook bleken zij vaker multidimen-
sionele palliatieve zorg te geven (p 0.024). In beide condities hadden de meeste geïdentifi-
ceerde patiënten een diagnose kanker.
We concludeerden dat de RADPAC huisartsen aanzet tot het identificeren van palliatieve 
patiënten. Getrainde huisartsen leveren meer multidimensionele palliatieve zorg. Verdere 
aanpassing en evaluatie van de RADPAC en aandacht voor multidimensionele palliatieve zorg 
zijn nodig voor de verbetering van proactieve palliatieve zorg voor patiënten met orgaan 
falen. 
Hoofdstuk 6 beschrijft hoe huisartsen en consulenten palliatieve zorg, de verschillende 
aspecten van de training en de invloed op de dagelijkse praktijk ervaren hebben. Huisartsen 
in de interventie groep werden getraind in tijdige identificatie van palliatieve patiënten 
met kanker, COPD of CHF en proactieve palliatieve zorgplanning. Huisartsen in de inter-
ventie groep kregen twee terugkombijeenkomsten aangeboden, waarin men met simulatie-
patiënten kon oefenen. Daarnaast konden huisartsen met een consulent palliatieve zorg, 
per geïdentificeerde patiënt, het gemaakte proactieve palliatieve zorg plan doorspreken en 
nader preciseren. Twee jaar na de training werden semigestructureerde interviews afge-
nomen bij huisartsen en focusgroep en interviews gehouden met consulenten palliatieve 
zorg. Een kwalitatieve inhoudsanalyse van de verzamelde data werd verricht. 
Zes consulenten en negen huisartsen namen deel aan de interviews. De meeste huisartsen 
vermeldden een positieve verandering in hun manier van denken en handelen ten aanzien 
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van vroege proactieve palliatieve zorg. Een deel van de huisartsen gebruikte de RADPAC 
nog, de meesten gaven aan zich deze indicatoren eigen gemaakt te hebben. Ongeveer de helft 
van de huisartsen vindt de gesprekken over het levenseinde moeilijk, vooral bij patiënten 
met orgaan falen. De overige huisartsen gaven aan na de training wat gemakkelijker dit 
gesprek aan te gaan. 
Ondanks dat de meeste huisartsen en consulenten positief waren over de training en toe-
passen in de dagelijkse praktijk, is er meer aandacht nodig in toekomstige onderzoeks-
programma’s voor vroegtijdige identificatie van voornamelijk palliatieve patiënten met 
COPD en CHF en voor het bespreken van hun toekomst.
In het laatste hoofdstuk van dit proefschrift, hoofdstuk 7, worden ten eerste de belangrijkste 
bevindingen en de sterke en zwakke punten van de verschillende onderzoeken bediscus-
sieerd en in een breder perspectief beschouwd. 
Ondanks de negatieve uitkomst van de RCT, lijkt de post-hoc analyse te wijzen op een moge-
lijk positief effect van de interventie op verschillende aspecten van palliatieve zorg in de 
eerste lijn. We bediscussiëren vier mogelijke verklaringen waarom het voor huisartsen 
moeilijk is routinematig proactieve palliatieve zorg te verlenen. 
1.  Het concept vroeg identificatie van palliatieve patiënten.
2.  De RADPAC heeft geen aspecten ten aanzien van een van de pijlers van de huisartsge-
neeskunde, namelijk, de context van de patiënt.
3.  Het gebrek aan bewustzijn van de voordelen van het vroeg starten met proactieve pallia-
tieve zorg, naast de op ziekte gerichte behandeling onder de verschillende professionals 
in de gezondheidszorg.
4.  De ervaren grenzen in het bespreken van proactieve palliatieve zorg met patiënten en 
hun naasten.
Ten tweede worden enkele algemene maatschappelijke discussiepunten ten aanzien van 
palliatieve zorg besproken. De belangrijkste boodschap van de algemene maatschappelijke 
discussie is de noodzaak tot bewustwording van wat palliatieve zorg is, in alle lagen van de 
maatschappij. 
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nog eens na te denken over ‘toch promoveren’. Dat heb ik gedaan, zie hier het resultaat! Ik 
heb geboft met jou als copromotor! Trouwens, de filmtips mochten er ook wezen. Marieke, 
we begonnen als duo aan dit onderzoek; sparringsmaatjes op ‘de Buitenhoek’ en niet alleen 
over serieuze onderzoekszaken. Ik heb ontzettend veel van je geleerd. Ik wil je bedanken 
voor je bemoedigende woorden als ik niet meer wist hoe het allemaal voor elkaar te krij-
gen. Oneindig veel kopjes koffie hebben we gedronken en gelachen om onze ‘palliatieve-
handenfoto’-muur. 
Kris Vissers, bedankt voor de steun en het vertrouwen dat je me de afgelopen jaren gegeven 
hebt. De weg is niet zonder hobbels geweest, maar ik weet inmiddels dat dit voor promo-
veren eigenlijk heel normaal is…  
Chris van Weel, voor mijn gevoel ken ik je al sinds ik mijn eerste stappen in de prekliniek 
zette. Ik wil je bedanken voor je vertrouwen, de inbreng vanuit je huisartsgeneeskundige-
helikopter visie en voor je opbouwende feedback.  
Stans Verhagen, vanaf het begin ben je intensief bij het onderzoek betrokken geweest. 
Bedankt dat ik gebruik heb mogen maken van je immens uitgebreide kennis. 
Alle deelnemende huisartsen, hun assistentes, de geïncludeerde patiënten en hun naasten 
wil ik bedanken. Zonder hen zou dit onderzoek niet hebben kunnen slagen, en er zelfs hele-
maal niet zijn geweest. Mijn drijfveer om een bijdrage te leven aan de dagelijkse huisarts-
praktijk, ligt hierin besloten. 
Voor het verzamelen van de data wil ik de volgende onderzoeksassistenten en stagiaires 
bedanken: Naomi Reitsma, Irene Loman, Bram Lestrade, Annelies van Bruggen, Aletta 
Moelands, Paul Konings, Stefanie Gerritzen en Sanne Heijmans. 
Cora Leijdens en Marjo van Bommel, bedankt voor het enthousiasme waarmee jullie de 
trainingen hebben gegeven.
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Mijn collega’s, aanvankelijk op ‘de Buitenhoek’, daarna ‘De omloop’ en nu op de 4de: Franca, 
Kathrin, Jeroen H., Jelle, Patrick, Kalinka, Nasira, Annette, Hans, Jasper, Anne, Marlieke, Ria, 
Marianne, Tijn en Jackie (hopelijk vergeet ik niemand), bedankt voor de gezelligheid en alle 
bemoedigende woorden. Franca, ik wil je bedanken voor je vriendschap. We bespraken naast 
onderzoeksperikelen, ook huisartsvak- en privéperikelen. Ben benieuwd welke vraag je gaat 
stellen! Jelle (Julle), op je vraag ’En, wanneer ga je promoveren?’ weet ik eindelijk het antwoord!
Jeroen F., een woord voor jou: Collega van de buitenhoek, mijn oudste gepensioneerde vriend. 
Ik wil je hier bedanken, voor je vriendschap, je creativiteit en je humor. Snel weer een wijntje 
bij Frowijn?
Eric, ook jou ben ik dank verschuldigd. Je maakte in de eerste jaren van het onderzoek deel 
uit van de directe begeleiding van mijn onderzoek en promotie. Je input als huisarts en onder-
zoeker waren van grote waarde. Niet alleen voor het onderzoek, ook voor mij als persoon. 
Een speciale plek voor de ‘Ottenhoff’. Jaap, ik wil je bedanken voor je vertrouwen. Ik heb onze 
overlegmomenten als verrijkend ervaren. Ik vind het inspirerend, hoe je naast patiënten-
zorg de praktijk runt en dit weet te combineren met eigen initiatieven om ‘palliatieve zorg 
in de eerste lijn’ te verrijken.
Mo, Henny, Brigit, Patty, Jan, zonder jullie is er geen praktijk ‘Ottenhoff’. Bedankt! 
Mijn familie en vrienden, jullie zijn onmisbaar in mijn leven. Bedankt voor de onvoorwaar-
delijke steun en vriendschap! Hysfijne vrienden, wat ben ik ontzettend blij met jullie! Onze 
twee jaarlijkse ‘decadente’ vakanties zijn ongeëvenaard en de slagroom op onze vriendschap! 
‘Super-visie’ vriendinnen, hoe fantastisch dat wij elkaar hebben leren kennen! Dames van 
het VWO, bedankt voor onze jarenlange vriendschap. Ik durf bijna niet uit te rekenen, hoe 
lang dat al is. 
Ieke, Sami, Floortje, Isa en Roos, jullie wil ik bedanken dat ik deel uit mag maken van jullie 
gezin. Ontzettend bedankt voor de lieve woorden en de fijne knuffels. Ieke, ik wil je bedanken 
voor je vertrouwen, je vermogen om andere vragen te stellen en je vriendschap. Wat ont-
zettend fijn dat je mijn paranimf wilt zijn!
Irene, wat geniet ik ontzettend van onze vriendschap en vakantieavonturen! Bedankt dat 
ook jij mijn paranimf wilt zijn! 
Lieve Pap en Mam, Lieve Anne en Nynke, Lieve Mark en Floris en Lieve Mats, Jens, Mia, 
Mare en Wout. Ik kan niet vertellen hoeveel jullie voor me betekenen. Bedankt voor al jullie 
steun en liefde!
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